Triggering	O
of	O
the	O
human	O
interleukin-6	O
gene	O
by	O
interferon-gamma	O
and	O
tumor	O
necrosis	O
factor-alpha	O
in	O
monocytic	O
cells	O
involves	O
cooperation	O
between	O
interferon	B-protein
regulatory	I-protein
factor-1	I-protein
,	O
NF	B-protein
kappa	I-protein
B	I-protein
,	O
and	O
Sp1	B-protein
transcription	B-protein
factors	I-protein
.	O

We	O
investigated	O
the	O
molecular	O
basis	O
of	O
the	O
synergistic	O
induction	O
by	O
interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
/	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
of	O
human	B-DNA
interleukin-6	I-DNA
(	I-DNA
IL-6	I-DNA
)	I-DNA
gene	I-DNA
in	O
THP-1	B-cell_type
monocytic	I-cell_type
cells	I-cell_type
,	O
and	O
compared	O
it	O
with	O
the	O
basis	O
of	O
this	O
induction	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

Functional	O
studies	O
with	O
IL-6	B-DNA
promoter	I-DNA
demonstrated	O
that	O
three	O
regions	O
are	O
the	O
targets	O
of	O
the	O
IFN-gamma	B-protein
and/or	O
TNF-alpha	B-protein
action	O
,	O
whereas	O
only	O
one	O
of	O
these	O
regions	O
seemed	O
to	O
be	O
implicated	O
in	O
LPS	O
activation	O
.	O

The	O
three	O
regions	O
concerned	O
are	O
:	O
1	O
)	O
a	O
region	O
between	O
-73	O
and	O
-36	O
,	O
which	O
is	O
the	O
minimal	B-DNA
element	I-DNA
inducible	O
by	O
LPS	O
or	O
TNF-alpha	B-protein
;	O
2	O
)	O
an	O
element	O
located	O
between	O
-181	O
and	O
-73	O
,	O
which	O
appeared	O
to	O
regulate	O
the	O
response	O
to	O
IFN-gamma	B-protein
and	O
TNF-alpha	B-protein
negatively	O
;	O
and	O
3	O
)	O
a	O
distal	B-DNA
element	I-DNA
upstream	I-DNA
of	O
-224	O
,	O
which	O
was	O
inducible	O
by	O
IFN-gamma	B-protein
alone	O
.	O

LPS	O
signaling	O
was	O
found	O
to	O
involve	O
NF	B-protein
kappa	I-protein
B	I-protein
activation	O
by	O
the	O
p50/p65	B-protein
heterodimers	I-protein
.	O

Synergistic	O
induction	O
of	O
the	O
IL-6	B-DNA
gene	I-DNA
by	O
IFN-gamma	B-protein
and	O
TNF-alpha	B-protein
,	O
in	O
monocytic	B-cell_type
cells	I-cell_type
,	O
involved	O
cooperation	O
between	O
the	O
IRF-1	B-protein
and	O
NF	B-protein
kappa	I-protein
B	I-protein
p65	I-protein
homodimers	I-protein
with	O
concomitant	O
removal	O
of	O
the	O
negative	O
effect	O
of	O
the	O
retinoblastoma	B-DNA
control	I-DNA
element	I-DNA
present	O
in	O
the	O
IL-6	B-DNA
promoter	I-DNA
.	O

This	O
removal	O
occurred	O
by	O
activation	O
of	O
the	O
constitutive	B-protein
Sp1	I-protein
factor	I-protein
,	O
whose	O
increased	O
binding	O
activity	O
and	O
phosphorylation	O
were	O
mediated	O
by	O
IFN-gamma	B-protein
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

46	NULL
,	NULL
Issue	NULL
of	NULL
November	NULL
17	NULL
,	NULL
pp	NULL
.	NULL

27920-27931	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Triggering	NULL
of	NULL
the	NULL
Human	NULL
Interleukin-6	NULL
Gene	NULL
by	NULL
Interferon-y	NULL
and	NULL
Tumor	NULL
Necrosis	NULL
Factor-	NULL
«	NULL
in	NULL
Monocytic	NULL
Cells	NULL
Involves	NULL
Cooperation	NULL
between	NULL
Interferon	NULL
Regulatory	NULL
Factor-1	NULL
,	NULL
NFB	NULL
,	NULL
and	NULL
Spl	NULL
Transcription	NULL
Factors*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
22	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
September	NULL
1	NULL
,	NULL
1995	NULL
)	NULL
Josiane	NULL
Sancéau	NULL
$	NULL
§	NULL
,	NULL
Tsuneyasu	NULL
Kaisho	NULL
{	NULL
,	NULL
Toshio	NULL
Hiranof	NULL
,	NULL
and	NULL
Juana	NULL
Wietzerbint	NULL
From	NULL
{	NULL
INSERM	NULL
,	NULL
U365	NULL
,	NULL
``	NULL
Interferons	NULL
et	NULL
Cytokines	NULL
,	NULL
``	NULL
Institut	NULL
Curie	NULL
,	NULL
Section	NULL
de	NULL
Recherches	NULL
,	NULL
26	NULL
,	NULL
rue	NULL
d'Ulm	NULL
,	NULL
75231	NULL
Paris	NULL
,	NULL
France	NULL
and	NULL
the	NULL
{	NULL
Biomedical	NULL
Research	NULL
Center	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Division	NULL
of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
2-2	NULL
Yamada-oka	NULL
,	NULL
Suita	NULL
,	NULL
Osaka	NULL
565	NULL
,	NULL
Japan	NULL
We	NULL
investigated	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
synergistic	NULL
induction	NULL
by	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
/tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-a	NULL
)	NULL
of	NULL
human	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
gene	NULL
in	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
,	NULL
and	NULL
compared	NULL
it	NULL
with	NULL
the	NULL
basis	NULL
of	NULL
this	NULL
induction	NULL
by	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
.	NULL

Functional	NULL
studies	NULL
with	NULL
IL-6	NULL
promoter	NULL
demonstrated	NULL
that	NULL
three	NULL
regions	NULL
are	NULL
the	NULL
targets	NULL
of	NULL
the	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
@	NULL
action	NULL
,	NULL
whereas	NULL
only	NULL
one	NULL
of	NULL
these	NULL
regions	NULL
seemed	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
LPS	NULL
activation	NULL
.	NULL

The	NULL
three	NULL
regions	NULL
concerned	NULL
are	NULL
:	NULL
1	NULL
)	NULL
a	NULL
region	NULL
between	NULL
-73	NULL
and	NULL
-36	NULL
,	NULL
which	NULL
is	NULL
the	NULL
minimal	NULL
element	NULL
inducible	NULL
by	NULL
LPS	NULL
or	NULL
TNF-a	NULL
;	NULL
2	NULL
)	NULL
an	NULL
element	NULL
located	NULL
between	NULL
-181	NULL
and	NULL
-73	NULL
,	NULL
which	NULL
appeared	NULL
to	NULL
regulate	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
negatively	NULL
;	NULL
and	NULL
3	NULL
)	NULL
a	NULL
distal	NULL
element	NULL
upstream	NULL
of	NULL
-224	NULL
,	NULL
which	NULL
was	NULL
inducible	NULL
by	NULL
IFN-y	NULL
alone	NULL
.	NULL

LPS	NULL
signaling	NULL
was	NULL
found	NULL
to	NULL
involve	NULL
NFxB	NULL
activation	NULL
by	NULL
the	NULL
p50/p65	NULL
heterodimers	NULL
.	NULL

Synergistic	NULL
induction	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
by	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
,	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
involved	NULL
cooperation	NULL
between	NULL
the	NULL
IRF-1	NULL
and	NULL
NFB	NULL
p65	NULL
homodimers	NULL
with	NULL
concomitant	NULL
removal	NULL
of	NULL
the	NULL
negative	NULL
effect	NULL
of	NULL
the	NULL
retinoblastoma	NULL
control	NULL
element	NULL
present	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
.	NULL

This	NULL
removal	NULL
occurred	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
constitutive	NULL
Spl	NULL
factor	NULL
,	NULL
whose	NULL
increased	NULL
binding	NULL
activity	NULL
and	NULL
phosphorylation	NULL
were	NULL
mediated	NULL
by	NULL
IFN-y	NULL
.	NULL

IL-6	NULL
``	NULL
is	NULL
a	NULL
multifunctional	NULL
cytokine	NULL
involved	NULL
in	NULL
controlling	NULL
many	NULL
cell	NULL
functions	NULL
,	NULL
including	NULL
antibody	NULL
synthesis	NULL
by	NULL
B	NULL
cells	NULL
,	NULL
T	NULL
cell	NULL
cytotoxicity	NULL
,	NULL
stem	NULL
cell	NULL
differentiation	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
acute	NULL
phase	NULL
proteins	NULL
.	NULL

IL-6	NULL
is	NULL
produced	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
noxious	NULL
stimuli	NULL
,	NULL
including	NULL
viral	NULL
and	NULL
bacterial	NULL
infections	NULL
(	NULL
I-4	NULL
)	NULL
.	NULL

Deficient	NULL
regulation	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
autoimmune	NULL
diseases	NULL
and	NULL
affects	NULL
normal	NULL
and	NULL
leukemic	NULL
hematopoiesis	NULL
(	NULL
4-9	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
demonstrated	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Institut	NULL
National	NULL
Scientifique	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
(	NULL
INSERM	NULL
)	NULL
and	NULL
the	NULL
Association	NULL
pour	NULL
le	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
ARC	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
INSERM	NULL
U365	NULL
,	NULL
``	NULL
Interferons	NULL
et	NULL
Cytokines	NULL
,	NULL
``	NULL
Institut	NULL
Curie	NULL
,	NULL
Section	NULL
de	NULL
Recherches	NULL
,	NULL
26	NULL
,	NULL
rue	NULL
d'Ulm	NULL
,	NULL
75281	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
38-1-4825-8267	NULL
;	NULL
Fax	NULL
:	NULL
38-1-4407-0785	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL-6	NULL
,	NULL
interleukin-6	NULL
;	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
IRF-1	NULL
,	NULL
interferon-regulatory	NULL
factor	NULL
1	NULL
;	NULL
RCE	NULL
,	NULL
retinoblastoma	NULL
control	NULL
element	NULL
;	NULL
FCS	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
MOPS	NULL
,	NULL
4-morpholinepropanesulfonic	NULL
acid	NULL
;	NULL
ISRE	NULL
,	NULL
response	NULL
element	NULL
;	NULL
ISGF3	NULL
,	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3.	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
defect	NULL
in	NULL
IL-6	NULL
production	NULL
in	NULL
Fanconi	NULL
's	NULL
anemia	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
is	NULL
partly	NULL
responsible	NULL
for	NULL
the	NULL
altered	NULL
hemopoiesis	NULL
in	NULL
Fanconi	NULL
's	NULL
anemia	NULL
patients	NULL
.	NULL

The	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
present	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
gene	NULL
have	NULL
been	NULL
studied	NULL
by	NULL
several	NULL
laboratories	NULL
.	NULL

Various	NULL
elements	NULL
responsible	NULL
for	NULL
IL-6	NULL
gene	NULL
induction	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
including	NULL
phorbol	NULL
12-my-ristate	NULL
13-acetate	NULL
,	NULL
cAMP	NULL
,	NULL
NFkB	NULL
,	NULL
NF-IL-6	NULL
,	NULL
and	NULL
multiple	NULL
cyto-kine-responsive	NULL
elements	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
12-16	NULL
)	NULL
.	NULL

Tumor	NULL
suppressor	NULL
gene	NULL
products	NULL
p53	NULL
and	NULL
pRB	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
suppress	NULL
IL-6	NULL
promoter	NULL
activity	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Different	NULL
laboratories	NULL
,	NULL
including	NULL
ours	NULL
,	NULL
showed	NULL
that	NULL
there	NULL
are	NULL
cell	NULL
type-	NULL
dependent	NULL
differences	NULL
in	NULL
the	NULL
mechanism	NULL
and	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
IL-6	NULL
gene	NULL
induction	NULL
.	NULL

Thus	NULL
,	NULL
TNF-	NULL
«	NULL
induced	NULL
IL-6	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
18-21	NULL
)	NULL
,	NULL
but	NULL
it	NULL
failed	NULL
to	NULL
do	NULL
so	NULL
in	NULL
monocytes	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
20	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
IFN-y	NULL
is	NULL
an	NULL
essential	NULL
co-signal	NULL
for	NULL
TNF-a	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-6	NULL
in	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
acute	NULL
phase	NULL
reac-tion	NULL
,	NULL
and	NULL
hematopoiesis	NULL
,	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
monocytic	NULL
cells	NULL
appeared	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
major	NULL
physiological	NULL
sources	NULL
of	NULL
this	NULL
cytokine	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
analyze	NULL
the	NULL
molecular	NULL
mechanism	NULL
responsible	NULL
for	NULL
its	NULL
induction	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
by	NULL
different	NULL
inducers	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
has	NULL
been	NULL
extensively	NULL
studied	NULL
,	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
synergistic	NULL
IL-6	NULL
gene	NULL
induction	NULL
by	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
in	NULL
monocytic	NULL
cells	NULL
has	NULL
still	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

We	NULL
postulated	NULL
that	NULL
both	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
@	NULL
activate	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
should	NULL
act	NULL
simultaneously	NULL
to	NULL
induce	NULL
IL-6	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
hypothesis	NULL
was	NULL
supported	NULL
by	NULL
our	NULL
previous	NULL
finding	NULL
that	NULL
sequential	NULL
stimulation	NULL
with	NULL
IFN-y	NULL
,	NULL
followed	NULL
by	NULL
TNF-a	NULL
stimulation	NULL
,	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
IL-6	NULL
mRNA	NULL
induction	NULL
(	NULL
22	NULL
)	NULL
.	NULL

This	NULL
implied	NULL
that	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
induced	NULL
or	NULL
activated	NULL
different	NULL
transiently	NULL
expressed	NULL
components	NULL
,	NULL
which	NULL
must	NULL
act	NULL
together	NULL
in	NULL
cooperation	NULL
to	NULL
trigger	NULL
IL-6	NULL
gene	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
NFB	NULL
binding	NULL
activity	NULL
by	NULL
TNF-	NULL
«	NULL
contributes	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
monocytic	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
NFxB/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
consists	NULL
of	NULL
at	NULL
least	NULL
five	NULL
proteins	NULL
,	NULL
including	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
,	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p52	NULL
,	NULL
which	NULL
are	NULL
related	NULL
to	NULL
each	NULL
other	NULL
through	NULL
an	NULL
N-terminal	NULL
stretch	NULL
of	NULL
300	NULL
amino	NULL
acids	NULL
called	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

DNA	NULL
binding	NULL
occurs	NULL
through	NULL
dimerization	NULL
of	NULL
the	NULL
family	NULL
members	NULL
,	NULL
resulting	NULL
in	NULL
numerous	NULL
homo-	NULL
and	NULL
heterodimeric	NULL
combinations	NULL
of	NULL
NFxB/Rel	NULL
proteins	NULL
.	NULL

The	NULL
C-terminal	NULL
region	NULL
of	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
Rel-B	NULL
harbor	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
,	NULL
and	NULL
the	NULL
in	NULL
vivo	NULL
transcriptional	NULL
activity	NULL
is	NULL
attributed	NULL
to	NULL
the	NULL
p65-	NULL
,	NULL
c-Rel-	NULL
,	NULL
27920	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
and	NULL
Rel-B-containing	NULL
dimers	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
IFN-y-mediated	NULL
induction	NULL
of	NULL
IL-6	NULL
expression	NULL
are	NULL
not	NULL
known	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
IFN	NULL
«	NULL
/8	NULL
to	NULL
their	NULL
specific	NULL
receptors	NULL
rapidly	NULL
activates	NULL
a	NULL
latent	NULL
cytoplasmic	NULL
transcription	NULL
factor	NULL
,	NULL
ISGF3	NULL
(	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
)	NULL
.	NULL

ISGF3	NULL
is	NULL
transiently	NULL
activated	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
ISRE-dependent	NULL
transcription	NULL
(	NULL
24-27	NULL
)	NULL
.	NULL

Other	NULL
regulatory	NULL
factors	NULL
,	NULL
including	NULL
interferon-regulatory	NULL
factor	NULL
1	NULL
(	NULL
IRF-1	NULL
)	NULL
and	NULL
IRF-2	NULL
,	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IFN	NULL
system	NULL
.	NULL

IRF-1	NULL
and	NULL
IRF-2	NULL
bind	NULL
to	NULL
similar	NULL
cis	NULL
elements	NULL
within	NULL
type	NULL
I	NULL
IFN	NULL
and	NULL
IFN-inducible	NULL
genes	NULL
.	NULL

IRF-1	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
,	NULL
while	NULL
IRF-2	NULL
represses	NULL
IRF-1	NULL
function	NULL
(	NULL
28-33	NULL
)	NULL
.	NULL

Both	NULL
factors	NULL
appear	NULL
also	NULL
to	NULL
bind	NULL
specifically	NULL
to	NULL
ISRE	NULL
sequences	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

We	NULL
performed	NULL
a	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
IL-6	NULL
gene	NULL
using	NULL
transient	NULL
transfection	NULL
of	NULL
CAT	NULL
reporter	NULL
gene	NULL
linked	NULL
to	NULL
IL-6	NULL
promoter	NULL
,	NULL
in	NULL
order	NULL
to	NULL
clarify	NULL
the	NULL
molecular	NULL
mechanism	NULL
involved	NULL
in	NULL
the	NULL
synergistic	NULL
induction	NULL
by	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

The	NULL
monocytic	NULL
THP-1	NULL
cell	NULL
model	NULL
appears	NULL
to	NULL
be	NULL
particularly	NULL
suitable	NULL
for	NULL
molecular	NULL
dissection	NULL
of	NULL
IFN-y/TNF-a-mediated	NULL
synergistic	NULL
induction	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
,	NULL
because	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
the	NULL
IL-6	NULL
gene	NULL
is	NULL
not	NULL
constitutively	NULL
expressed	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
IL-6	NULL
promoter	NULL
constructs	NULL
,	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
analysis	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
synergistic	NULL
induction	NULL
of	NULL
IL-6	NULL
gene	NULL
by	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
involved	NULL
cooperation	NULL
between	NULL
IRF-1	NULL
and	NULL
NFxB	NULL
binding	NULL
elements	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
negative	NULL
effect	NULL
of	NULL
the	NULL
retinoblastoma	NULL
control	NULL
element	NULL
(	NULL
RCE	NULL
)	NULL
present	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
IL-6-RCE	NULL
)	NULL
.	NULL

This	NULL
IL-6-RCE	NULL
con-tained	NULL
,	NULL
among	NULL
other	NULL
components	NULL
,	NULL
a	NULL
core	NULL
5'-CCGCC-3	NULL
'	NULL
sequence	NULL
homologous	NULL
with	NULL
the	NULL
consensus	NULL
binding	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
the	NULL
target	NULL
of	NULL
the	NULL
Sp1	NULL
factor	NULL
.	NULL

Sp1	NULL
is	NULL
a	NULL
constitutively	NULL
expressed	NULL
transcription	NULL
factor	NULL
present	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cell	NULL
types	NULL
and	NULL
binds	NULL
a	NULL
GC-rich	NULL
consensus	NULL
sequence	NULL
present	NULL
in	NULL
many	NULL
cellular	NULL
and	NULL
viral	NULL
promoters	NULL
.	NULL

Spl	NULL
contains	NULL
three	NULL
zinc	NULL
fingers	NULL
that	NULL
mediate	NULL
DNA	NULL
binding	NULL
and	NULL
four	NULL
domains	NULL
that	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Upon	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
containing	NULL
the	NULL
GC	NULL
box	NULL
in	NULL
the	NULL
cell	NULL
nucleus	NULL
,	NULL
Sp1	NULL
becomes	NULL
phosphorylated	NULL
on	NULL
multiple	NULL
sites	NULL
by	NULL
double-stranded	NULL
DNA-dependent	NULL
kinase	NULL
(	NULL
37	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
specific	NULL
interaction	NULL
between	NULL
DNA-binding	NULL
domains	NULL
of	NULL
the	NULL
p65	NULL
subunit-NFxB	NULL
and	NULL
Sp1	NULL
bound	NULL
the	NULL
DNA	NULL
modulates	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
activation	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
contribution	NULL
of	NULL
IFN-y	NULL
to	NULL
the	NULL
triggering	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
involves	NULL
a	NULL
change	NULL
in	NULL
the	NULL
amount	NULL
and	NULL
phosphorylated	NULL
state	NULL
of	NULL
Sp1	NULL
,	NULL
together	NULL
with	NULL
the	NULL
induction	NULL
and	NULL
activation	NULL
of	NULL
IRF-1	NULL
.	NULL

These	NULL
factors	NULL
cooperate	NULL
synergistically	NULL
with	NULL
homodimer	NULL
p65-NF	NULL
xB	NULL
,	NULL
which	NULL
is	NULL
activated	NULL
by	NULL
TNF-a	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-THP-1	NULL
cells	NULL
(	NULL
strain	NULL
TB202	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
grown	NULL
(	NULL
7	NULL
%	NULL
CO	NULL
,	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
shown	NULL
to	NULL
be	NULL
endotoxin-free	NULL
(	NULL
<	NULL
0.1	NULL
IU/ml	NULL
;	NULL
Myoclone	NULL
,	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Reagents-rHulFN-y	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
2	NULL
x	NULL
10	NULL
``	NULL
units/mg	NULL
protein	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Roussel-Uclaf	NULL
(	NULL
Romainville	NULL
,	NULL
France	NULL
)	NULL
;	NULL
rHulFN-o2	NULL
was	NULL
provided	NULL
by	NULL
Shering	NULL
(	NULL
Kenilworth	NULL
,	NULL
NJ	NULL
)	NULL
;	NULL
rHuTNF-a	NULL
«	NULL
(	NULL
specific	NULL
activity	NULL
6	NULL
x	NULL
10	NULL
``	NULL
units/mg	NULL
protein	NULL
)	NULL
was	NULL
produced	NULL
by	NULL
Genentech	NULL
and	NULL
provided	NULL
by	NULL
Boeh-ringer-Ingelheim	NULL
(	NULL
Dr.	NULL
G.	NULL
R.	NULL
Adolf	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
;	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
,	NULL
serotype	NULL
0111	NULL
:	NULL
B4	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Rabbit	NULL
affinity-purified	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
human	NULL
Rb	NULL
,	NULL
Spl	NULL
,	NULL
IRF-1	NULL
,	NULL
IRF-2	NULL
,	NULL
and	NULL
NFkB	NULL
family	NULL
proteins	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Tebu	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Monoclonal	NULL
anti-phosphoserine	NULL
was	NULL
from	NULL
Sigma	NULL
.	NULL

Purified	NULL
Spl	NULL
protein	NULL
was	NULL
from	NULL
Promega	NULL
.	NULL

Enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
Western	NULL
blotting	NULL
kit	NULL
reagent	NULL
and	NULL
Rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
were	NULL
from	NULL
Amersham	NULL
(	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
.	NULL

27921	NULL
IL-6-CAT	NULL
Construct	NULL
and	NULL
the	NULL
5'-Deletion	NULL
Mutants-A	NULL
1.2-kilobase	NULL
pair	NULL
BamHI-Xhol	NULL
fragment	NULL
which	NULL
contained	NULL
the	NULL
IL-6	NULL
-flanking	NULL
region	NULL
of	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
was	NULL
deleted	NULL
by	NULL
using	NULL
the	NULL
Exo-mung	NULL
deletion	NULL
kit	NULL
(	NULL
Strat-agene	NULL
)	NULL
,	NULL
inserted	NULL
into	NULL
a	NULL
pCAT-Basic	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
at	NULL
the	NULL
Sail	NULL
blunt	NULL
end	NULL
and	NULL
HindIII	NULL
sites	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
following	NULL
plasmids	NULL
:	NULL
del	NULL
(	NULL
-181	NULL
)	NULL
(	NULL
-181	NULL
to	NULL
+14	NULL
)	NULL
,	NULL
del	NULL
(	NULL
-108	NULL
)	NULL
(	NULL
-108	NULL
to	NULL
+14	NULL
)	NULL
,	NULL
del	NULL
(	NULL
-78	NULL
)	NULL
(	NULL
-18	NULL
to	NULL
+14	NULL
)	NULL
,	NULL
and	NULL
del	NULL
(	NULL
-36	NULL
)	NULL
(	NULL
-86	NULL
to	NULL
+14	NULL
)	NULL
.	NULL

A	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
(	NULL
-224	NULL
to	NULL
+14	NULL
)	NULL
plasmid	NULL
was	NULL
generated	NULL
by	NULL
deleting	NULL
the	NULL
BamHI-Nhel	NULL
fragment	NULL
(	NULL
-1160	NULL
to	NULL
-224	NULL
)	NULL
.	NULL

All	NULL
resultant	NULL
plasmids	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

Transient	NULL
Transfections-2	NULL
X	NULL
10	NULL
``	NULL
THP-1	NULL
cells	NULL
(	NULL
logarithmic	NULL
growth	NULL
phase	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
)	NULL
suspended	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
DMEM	NULL
(	NULL
Dulbecco	NULL
's	NULL
minimal	NULL
essential	NULL
medium	NULL
,	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
were	NULL
mixed	NULL
gently	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
indicated	NULL
dried	NULL
supercoiled	NULL
IL-6	NULL
promoter-plasmid	NULL
DNAs	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pSV	NULL
-galactosidase	NULL
control	NULL
plasmid	NULL
as	NULL
an	NULL
internal	NULL
reference	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
purified	NULL
by	NULL
two	NULL
cycles	NULL
of	NULL
CsCl	NULL
gradient	NULL
)	NULL
and	NULL
were	NULL
electroporated	NULL
at	NULL
220	NULL
V	NULL
,	NULL
960	NULL
microfarads	NULL
,	NULL
for	NULL
42	NULL
ms	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
wired	NULL
to	NULL
an	NULL
electroporation	NULL
chamber	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
before	NULL
dilution	NULL
in	NULL
10	NULL
ml	NULL
of	NULL
prewarmed	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
1	NULL
h	NULL
later	NULL
with	NULL
IFN-y	NULL
(	NULL
400	NULL
units/ml	NULL
!	NULL
)	NULL

and/or	NULL
TNF-a	NULL
(	NULL
400	NULL
units/ml	NULL
)	NULL
,	NULL
or	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
in	NULL
fresh	NULL
RPMI	NULL
1640/10	NULL
%	NULL
FCS	NULL
.	NULL

After	NULL
stimulation	NULL
of	NULL
36	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
CAT	NULL
activity	NULL
,	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Gorman	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
.	NULL

Each	NULL
CAT	NULL
reaction	NULL
was	NULL
performed	NULL
with	NULL
20	NULL
pg	NULL
protein	NULL
extract	NULL
and	NULL
2.3	NULL
nmol	NULL
of	NULL
**C-labeled	NULL
chloramphenicol	NULL
(	NULL
54	NULL
mCi/	NULL
mmol	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

B-Galactosidase	NULL
enzyme	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
extracts	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
EMSA-To	NULL
prepare	NULL
nuclear	NULL
extracts	NULL
,	NULL
40	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
chilled	NULL
PBS	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
500	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
10	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
molybdate	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
l	NULL
fluoride	NULL
,	NULL
10	NULL
pg/ml	NULL
protease	NULL
inhibitors	NULL
(	NULL
pepstatin	NULL
,	NULL
leupeptin	NULL
,	NULL
aprotinin	NULL
)	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
swelling	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
glycerol	NULL
was	NULL
added	NULL
(	NULL
final	NULL
concentration	NULL
5	NULL
%	NULL
,	NULL
viv	NULL
)	NULL
and	NULL
nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
600	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
,	NULL
at	NULL
2	NULL
°C	NULL
.	NULL

After	NULL
rapid	NULL
washing	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
(	NULL
containing	NULL
140	NULL
mM	NULL
NaCl	NULL
instead	NULL
of	NULL
50	NULL
mM	NULL
)	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
gently	NULL
resuspended	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
storage	NULL
buffer	NULL
containing	NULL
10	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
400	NULL
mm	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmeth-ylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
vanadate	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
molybdate	NULL
,	NULL
and	NULL
10	NULL
ug/ml	NULL
protease	NULL
inhibitors	NULL
.	NULL

After	NULL
60	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
gentle	NULL
(	NULL
and	NULL
occasional	NULL
)	NULL
mixing	NULL
,	NULL
particulate	NULL
matter	NULL
was	NULL
eliminated	NULL
by	NULL
centrifugation	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Protein	NULL
content	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
determinated	NULL
using	NULL
Bradford	NULL
's	NULL
method	NULL
(	NULL
81	NULL
)	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
nuclear	NULL
protein	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
probe	NULL
(	NULL
20,000	NULL
cpm	NULL
)	NULL
in	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
5	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
15	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
500	NULL
ug/ml	NULL
BSA-FV	NULL
,	NULL
and	NULL
800	NULL
ug/ml	NULL
denaturated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
12.5	NULL
l	NULL
)	NULL
(	NULL
without	NULL
EDTA	NULL
in	NULL
the	NULL
case	NULL
of	NULL
SP1	NULL
oligonucleotide	NULL
probe	NULL
)	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
nucle-oprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
a	NULL
nondenaturing	NULL
electrophoresis	NULL
in	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
for	NULL
3	NULL
h	NULL
at	NULL
20	NULL
mA	NULL
in	NULL
1	NULL
X	NULL
TGE	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
,	NULL
180	NULL
mM	NULL
glycine	NULL
,	NULL
and	NULL
2.5	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
in	NULL
refrigerated	NULL
condition	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
exposed	NULL
overnight	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
oligonucleotides	NULL
was	NULL
added	NULL
15	NULL
min	NULL
before	NULL
incubation	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
the	NULL
end-labeled	NULL
oligonucleotides	NULL
,	NULL
while	NULL
antisera	NULL
were	NULL
mixed	NULL
directly	NULL
with	NULL
nuclear	NULL
extracts	NULL
and	NULL
binding	NULL
buffer	NULL
(	NULL
without	NULL
salmon	NULL
sperm	NULL
DNA	NULL
)	NULL
1	NULL
h	NULL
before	NULL
adding	NULL
salmon	NULL
sperm	NULL
DNA	NULL
and	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Immunoblot	NULL
Analysis-Nuclear	NULL
protein	NULL
samples	NULL
(	NULL
150	NULL
ug	NULL
)	NULL
were	NULL
precleared	NULL
with	NULL
rabbit	NULL
IgG	NULL
nonimmune	NULL
antisera	NULL
and	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

After	NULL
centrifugation	NULL
(	NULL
5	NULL
min	NULL
,	NULL
4	NULL
°C	NULL
)	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
specific	NULL
antibodies	NULL
(	NULL
1:500°	NULL
``	NULL
°	NULL
dilution	NULL
)	NULL
overnight	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
then	NULL
8	NULL
mg	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
was	NULL
added	NULL
and	NULL
gently	NULL
rocked	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Protein	NULL
A-	NULL
and	NULL
protein	NULL
G-Sepharose	NULL
were	NULL
swollen	NULL
in	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
,	NULL
500	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.5	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
ug/ml	NULL
protease	NULL
inhibitors	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
molybdate	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

The	NULL
protein	NULL
G-Sepharose	NULL
immunocomplexes	NULL
were	NULL
successively	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
100	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
,	NULL
500	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
once	NULL
with	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaC	NULL
)	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
once	NULL
with	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.8	NULL
)	NULL
.	NULL

All	NULL
washes	NULL
were	NULL
performed	NULL
with	NULL
buffers	NULL
containing	NULL
the	NULL
anti-proteases	NULL
and	NULL
anti-phosphatases	NULL
mixture	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
eluted	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
3	NULL
%	NULL
SDS	NULL
,	NULL
30	NULL
%	NULL
glycerol	NULL
,	NULL
150	NULL
mM	NULL
KCl	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
6.7	NULL
)	NULL
,	NULL
200	NULL
mM	NULL
B-mercapto	NULL
ethanol	NULL
(	NULL
10	NULL
min	NULL
at	NULL
95	NULL
°C	NULL
)	NULL
,	NULL
and	NULL
specific	NULL
immunoprotein	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27922	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
0.45	NULL
uM	NULL
,	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
in	NULL
refrigerated	NULL
conditions	NULL
(	NULL
200	NULL
mA	NULL
,	NULL
5	NULL
h	NULL
)	NULL
.	NULL

BSA-saturated	NULL
membranes	NULL
were	NULL
incubated	NULL
first	NULL
with	NULL
a	NULL
specific	NULL
antibody	NULL
(	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
1:500	NULL
dilution	NULL
,	NULL
in	NULL
PBS	NULL
5	NULL
%	NULL
BSA-FV	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
**	NULL
``	NULL
I-protein	NULL
A	NULL
(	NULL
Amersham	NULL
,	NULL
500,000	NULL
cpm/ml	NULL
!	NULL

of	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
BSA-FV	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
20	NULL
°C	NULL
.	NULL

After	NULL
extensive	NULL
washing	NULL
,	NULL
membranes	NULL
were	NULL
exposed	NULL
to	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Shift-Western	NULL
Blotting-Protein-DNA	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
Western	NULL
blots	NULL
were	NULL
done	NULL
by	NULL
semidry	NULL
blotting	NULL
using	NULL
the	NULL
Multiphor	NULL
II	NULL
NovaBlot	NULL
electrophoretic	NULL
transfer	NULL
unit	NULL
(	NULL
Pharmacia	NULL
)	NULL
as	NULL
described	NULL
by	NULL
Demezuk	NULL
et	NULL
al	NULL
.	NULL

(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
first	NULL
filter	NULL
below	NULL
the	NULL
gel	NULL
was	NULL
nitrocellulose	NULL
(	NULL
BAS5	NULL
,	NULL
0.45	NULL
um	NULL
,	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
second	NULL
anion-exchange	NULL
filter	NULL
DEAE	NULL
membrane	NULL
(	NULL
Shleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

Radiolabeled	NULL
components	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
on	NULL
DEAE	NULL
membrane	NULL
.	NULL

For	NULL
protein	NULL
detection	NULL
,	NULL
BAS85	NULL
membrane	NULL
was	NULL
first	NULL
blocked	NULL
as	NULL
described	NULL
above	NULL
for	NULL
immunoblot	NULL
analysis	NULL
;	NULL
primary	NULL
antibodies	NULL
were	NULL
applied	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:1000	NULL
,	NULL
and	NULL
ECL	NULL
detection	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
procedures	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Nucleotide	NULL
Sequences	NULL
of	NULL
Oligonucleotides	NULL
Used	NULL
in	NULL
This	NULL
Study-Puri-fied	NULL
synthetic	NULL
oligonucleotides	NULL
were	NULL
provided	NULL
by	NULL
Eurogentec	NULL
(	NULL
Seraing	NULL
,	NULL
Belgium	NULL
)	NULL
,	NULL
and	NULL
covered	NULL
IL-6	NULL
promoter	NULL
fragments	NULL
between	NULL
-73	NULL
and	NULL
-54	NULL
(	NULL
A	NULL
;	NULL
5'-ctagaTGGGTTTTCCCATGAGTTCTt-3	NULL
'	NULL
)	NULL
,	NULL
between	NULL
-126	NULL
and	NULL
-101	NULL
(	NULL
B	NULL
;	NULL
5'-ctagaGCCCCACCCGCTCTGGCCCCACCCTCt-3	NULL
'	NULL
)	NULL
,	NULL
between	NULL
-173	NULL
and	NULL
-145	NULL
(	NULL
C	NULL
;	NULL
5'-ctagaATGCTAAAGGACGTAACATTGCA-CAATCTt-3	NULL
'	NULL
)	NULL
,	NULL
between	NULL
-207	NULL
and	NULL
-184	NULL
(	NULL
D	NULL
;	NULL
5'-ctagaCTAAGCT-GAACTTTTCCCCCTAGTt-3	NULL
'	NULL
)	NULL
,	NULL
between	NULL
-283	NULL
and	NULL
-242	NULL
(	NULL
E	NULL
;	NULL
5'-ctagaTGAGTCACTAATAAAAGAAAAAAGAAAGTAAGGAAGAGTG-Gt-3	NULL
'	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
with	NULL
mutated	NULL
sequences	NULL
were	NULL
also	NULL
used	NULL
:	NULL
-283	NULL
mt15	NULL
,	NULL
5'-ctagaTGGTTAGATAATAAAAGAAAAAAGAAAGTAAAGGAA-GAGTGGt-3	NULL
'	NULL
,	NULL
and	NULL
-283	NULL
mtl	NULL
,	NULL
5'-ctagaTGAGTCACTAATAAAA-GAAAAAAGAAAGTCGCATAAGAGTGGt-3	NULL
'	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
we	NULL
used	NULL
synthetic	NULL
oligonucleotides	NULL
covering	NULL
:	NULL
(	NULL
i	NULL
)	NULL
the	NULL
NFkB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
human	NULL
immunoglobulin	NULL
«	NULL
light	NULL
chain	NULL
enhancer	NULL
(	NULL
42	NULL
)	NULL
5'-ctagaCAGAGGGGATTTCCGAGAGGTt-3	NULL
'	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
IFN-o-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
of	NULL
2',5'-oligo	NULL
(	NULL
A	NULL
)	NULL
synthetase	NULL
(	NULL
43	NULL
)	NULL
5'-ctagaGATCCATGCCTCGGGAAAGGGAAACCGAAACTGAAGCCt-3	NULL
'	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
the	NULL
C3-IRF	NULL
(	NULL
44	NULL
)	NULL
5'-ctagaAAGGGAAAGGGAAAGGGAAAGGGt-3	NULL
'	NULL
,	NULL
(	NULL
iv	NULL
)	NULL
the	NULL
AP-1	NULL
consensus	NULL
motif	NULL
5	NULL
-ctagaTGAGTCACTGAGTCACTGAGT-CACt-3	NULL
'	NULL
,	NULL
and	NULL
(	NULL
v	NULL
)	NULL
the	NULL
SP1	NULL
consensus	NULL
motif	NULL
5'-ctagaGATGGGCGGAGT-TAGGGGCGGGACTATCt-3	NULL
'	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
lowercase	NULL
letters	NULL
represent	NULL
the	NULL
bases	NULL
included	NULL
for	NULL
creating	NULL
restriction	NULL
sites	NULL
.	NULL

The	NULL
underlined	NULL
letters	NULL
indicate	NULL
the	NULL
mutated	NULL
bases	NULL
.	NULL

After	NULL
annealing	NULL
,	NULL
the	NULL
synthetic	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
end-labeled	NULL
using	NULL
the	NULL
Klenow-DNA	NULL
po-lymerase	NULL
and	NULL
(	NULL
DuPont	NULL
NEN	NULL
)	NULL
and	NULL
were	NULL
purified	NULL
on	NULL
Elutip*	NULL
columns	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

RNA	NULL
Extraction	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
denaturation	NULL
in	NULL
guanidinium	NULL
thiocyanate	NULL
,	NULL
followed	NULL
by	NULL
pelleting	NULL
through	NULL
a	NULL
cesium	NULL
chloride	NULL
cushion	NULL
(	NULL
40	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
total	NULL
RNAs	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
in	NULL
MOPS	NULL
buffer	NULL
,	NULL
containing	NULL
0,7	NULL
%	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
onto	NULL
nylon	NULL
Hy-bond	NULL
N*	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Probe	NULL
hybridizations	NULL
(	NULL
10°	NULL
epm/m	NULL
!	NULL

l	NULL
)	NULL
were	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
65	NULL
°C	NULL
in	NULL
a	NULL
Rapid	NULL
Hybridization	NULL
Buffer	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

cDNA	NULL
Probes-The	NULL
cDNA	NULL
probe	NULL
for	NULL
human	NULL
IRF-1	NULL
was	NULL
a	NULL
0.9-kilobase	NULL
KpnI	NULL
fragment	NULL
excised	NULL
from	NULL
pUCIRF-1	NULL
vector	NULL
.	NULL

The	NULL
human	NULL
IRF-2	NULL
cDNA	NULL
was	NULL
a	NULL
1.2-kilobase	NULL
Xbal	NULL
fragment	NULL
excised	NULL
from	NULL
pHIRF4S-51	NULL
vector	NULL
.	NULL

These	NULL
cDNAs	NULL
were	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
T.	NULL
Taniguchi	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
using	NULL
the	NULL
Redi-prime	NULL
random	NULL
primer	NULL
labeling	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
using	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
(	NULL
DuPont	NULL
NEN	NULL
)	NULL
.	NULL

DNA	NULL
Extraction-Plasmid	NULL
DNA	NULL
were	NULL
prepared	NULL
with	NULL
the	NULL
Qiagen	NULL
plasmid	NULL
kit	NULL
(	NULL
Qiagen	NULL
,	NULL
Coger	NULL
,	NULL
France	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
two	NULL
cycles	NULL
of	NULL
purification	NULL
of	NULL
closed	NULL
circular	NULL
DNA	NULL
by	NULL
equilibrium	NULL
centrifugation	NULL
in	NULL
CsCl-ethidium	NULL
bromide	NULL
gradients	NULL
(	NULL
40	NULL
)	NULL
.	NULL

RESULTS	NULL
Functional	NULL
Analysis	NULL
of	NULL
5	NULL
Cis-regulatory	NULL
Elements	NULL
of	NULL
the	NULL
Human	NULL
IL-6	NULL
Gene-Functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
gene	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
-	NULL
1200	NULL
to	NULL
+14	NULL
fragment	NULL
as	NULL
well	NULL
as	NULL
a	NULL
series	NULL
of	NULL
5'-deletion	NULL
mutants	NULL
of	NULL
IL-6	NULL
promoter	NULL
,	NULL
linked	NULL
to	NULL
a	NULL
reporter	NULL
pCAT-basic	NULL
plasmid	NULL
,	NULL
which	NULL
lacks	NULL
both	NULL
enhancer	NULL
and	NULL
promoter	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
used	NULL
to	NULL
transfect	NULL
THP-1	NULL
cells	NULL
by	NULL
electroporation	NULL
,	NULL
and	NULL
1	NULL
h	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
either	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
,	NULL
or	NULL
by	NULL
LPS	NULL
,	NULL
and	NULL
tested	NULL
for	NULL
CAT	NULL
activity	NULL
after	NULL
36	NULL
h.	NULL
When	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
construct	NULL
containing	NULL
1200	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
IL-6	NULL
-flanking	NULL
region	NULL
,	NULL
they	NULL
exhibited	NULL
a	NULL
5-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
combined	NULL
treatment	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
,	NULL
and	NULL
a	NULL
2.5-fold	NULL
increase	NULL
after	NULL
IFN-y	NULL
treatment	NULL
,	NULL
but	NULL
displayed	NULL
no	NULL
significant	NULL
response	NULL
to	NULL
TNF-	NULL
@	NULL
alone	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
LPS	NULL
induced	NULL
a	NULL
7-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observations	NULL
reported	NULL
by	NULL
other	NULL
groups	NULL
for	NULL
other	NULL
cell	NULL
systems	NULL
(	NULL
8	NULL
,	NULL
4	NULL
,	NULL
17-20	NULL
)	NULL
.	NULL

Deletions	NULL
of	NULL
the	NULL
regions	NULL
between	NULL
-1200	NULL
and	NULL
-224	NULL
and	NULL
between	NULL
-1200	NULL
and	NULL
-181	NULL
resulted	NULL
in	NULL
constructs	NULL
whose	NULL
respective	NULL
CAT	NULL
activities	NULL
rose	NULL
4-fold	NULL
and	NULL
2.5-fold	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
«	NULL
treatment	NULL
,	NULL
and	NULL
5-fold	NULL
and	NULL
4-fold	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
region	NULL
spanning	NULL
nucleotides	NULL
-1200	NULL
to	NULL
-224	NULL
abolished	NULL
the	NULL
sensitivity	NULL
to	NULL
IFN-y	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
fragment	NULL
up	NULL
to	NULL
nucleotide	NULL
-108	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
the	NULL
synergistic	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
stimulation	NULL
,	NULL
whereas	NULL
2-fold	NULL
CAT	NULL
activity	NULL
was	NULL
still	NULL
observed	NULL
after	NULL
LPS	NULL
.	NULL

Although	NULL
successive	NULL
deletions	NULL
at	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
fragment	NULL
resulted	NULL
in	NULL
a	NULL
progressive	NULL
reduction	NULL
of	NULL
the	NULL
inducibility	NULL
of	NULL
CAT	NULL
activity	NULL
by	NULL
LPS	NULL
,	NULL
the	NULL
construct	NULL
containing	NULL
the	NULL
region	NULL
from	NULL
-73	NULL
to	NULL
+14	NULL
retained	NULL
its	NULL
sensitivity	NULL
to	NULL
LPS	NULL
and	NULL
continued	NULL
to	NULL
display	NULL
a	NULL
3-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
.	NULL

It	NULL
was	NULL
interesting	NULL
to	NULL
observe	NULL
that	NULL
this	NULL
fragment	NULL
became	NULL
inducible	NULL
by	NULL
TNF-a	NULL
and	NULL
exhibited	NULL
a	NULL
2-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
no	NULL
synergistic	NULL
effect	NULL
was	NULL
induced	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
region	NULL
from	NULL
-1200	NULL
to	NULL
-36	NULL
resulted	NULL
in	NULL
the	NULL
complete	NULL
loss	NULL
of	NULL
inducibility	NULL
by	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
@	NULL
,	NULL
and	NULL
by	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
deletion	NULL
analysis	NULL
described	NULL
above	NULL
suggested	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
three	NULL
regions	NULL
differentially	NULL
involved	NULL
in	NULL
IL-6	NULL
gene	NULL
regulation	NULL
by	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
«	NULL
,	NULL
and	NULL
by	NULL
LPS	NULL
.	NULL

The	NULL
first	NULL
region	NULL
is	NULL
a	NULL
distal	NULL
fragment	NULL
between	NULL
-1200	NULL
and	NULL
-224	NULL
that	NULL
positively	NULL
regulates	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
alone	NULL
.	NULL

Although	NULL
deletion	NULL
of	NULL
this	NULL
fragment	NULL
does	NULL
not	NULL
eliminate	NULL
the	NULL
synergistic	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
response	NULL
,	NULL
a	NULL
slide	NULL
reduction	NULL
in	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
is	NULL
observed	NULL
.	NULL

Com-puter-based	NULL
observation	NULL
showed	NULL
that	NULL
this	NULL
fragment	NULL
contains	NULL
an	NULL
AP-1	NULL
site	NULL
between	NULL
-283	NULL
and	NULL
-277	NULL
,	NULL
and	NULL
a	NULL
copy	NULL
of	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
5'-AAAGGA-3	NULL
'	NULL
(	NULL
-253/-248	NULL
)	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
second	NULL
region	NULL
is	NULL
a	NULL
repressor	NULL
element	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
sequence	NULL
between	NULL
-181	NULL
and	NULL
-73	NULL
,	NULL
which	NULL
would	NULL
negatively	NULL
affect	NULL
the	NULL
synergistic	NULL
response	NULL
to	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
«	NULL
without	NULL
affecting	NULL
sensitivity	NULL
to	NULL
LPS	NULL
.	NULL

This	NULL
IL-6	NULL
DNA	NULL
sequence	NULL
contains	NULL
,	NULL
from	NULL
-126	NULL
to	NULL
-101	NULL
,	NULL
a	NULL
direct	NULL
repeat	NULL
which	NULL
is	NULL
strikingly	NULL
similar	NULL
to	NULL
the	NULL
c-fos	NULL
basal	NULL
transcription	NULL
element	NULL
,	NULL
with	NULL
21/26	NULL
nucleotides	NULL
matching	NULL
the	NULL
RB-repressible	NULL
RCE	NULL
(	NULL
the	NULL
RB	NULL
control	NULL
element	NULL
)	NULL
identified	NULL
in	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
17	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
this	NULL
connection	NULL
,	NULL
Santhanam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
showed	NULL
in	NULL
functional	NULL
assays	NULL
that	NULL
the	NULL
overexpression	NULL
of	NULL
wild	NULL
type	NULL
RB	NULL
in	NULL
Hela	NULL
cells	NULL
strongly	NULL
repressed	NULL
the	NULL
activity	NULL
of	NULL
IL-6	NULL
promoter	NULL
constructs	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
two	NULL
elements	NULL
,	NULL
a	NULL
third	NULL
region	NULL
located	NULL
between	NULL
-73	NULL
and	NULL
-36	NULL
,	NULL
probably	NULL
corresponding	NULL
to	NULL
the	NULL
minimal	NULL
element	NULL
necessary	NULL
for	NULL
the	NULL
LPS	NULL
response	NULL
,	NULL
also	NULL
allowed	NULL
TNF-a	NULL
sensitivity	NULL
.	NULL

Within	NULL
this	NULL
fragment	NULL
were	NULL
a	NULL
putative	NULL
AP-1	NULL
motif	NULL
(	NULL
-61	NULL
to	NULL
-55	NULL
)	NULL
and	NULL
the	NULL
sequence	NULL
TCC-3	NULL
'	NULL
(	NULL
-72	NULL
to	NULL
-63	NULL
)	NULL
,	NULL
which	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
immunoglobulin	NULL
x	NULL
light-chain	NULL
enhancer	NULL
sequence	NULL
5'-GGGG-ACTTTCC-3	NULL
'	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
Nuclear	NULL
Protein	NULL
(	NULL
s	NULL
)	NULL
Binding	NULL
to	NULL
the	NULL
IL-6	NULL
Promoter	NULL
DNA	NULL
Fragments	NULL
after	NULL
Stimulation	NULL
of	NULL
THP-1	NULL
Cells-To	NULL
determine	NULL
whether	NULL
IFN-y	NULL
and/or	NULL
TNF-	NULL
«	NULL
@	NULL
induced	NULL
the	NULL
binding	NULL
of	NULL
factors	NULL
that	NULL
specifically	NULL
recognize	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
,	NULL
we	NULL
prepared	NULL
double-stranded	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
IL-6	NULL
promoter	NULL
DNA	NULL
motif	NULL
targets	NULL
of	NULL
specific	NULL
transacting	NULL
factors	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
IL-6	NULL
gene	NULL
induction	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
3	NULL
,	NULL
12-16	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
,	NULL
prepared	NULL
from	NULL
both	NULL
untreated	NULL
cells	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
27923	NULL
A	NULL
Oligo	NULL
A	NULL
A	NULL
-283	NULL
£240	NULL
Oligo	NULL
B	NULL
s	NULL
___	NULL
``	NULL
___	NULL
104	NULL
73	NULL
\	NULL
/	NULL
/	NULL
/	NULL
/	NULL
Ma|orIL6	NULL
c-fos	NULL
SRE	NULL
\	NULL
,	NULL
NFKB	NULL
start	NULL
1200	NULL
283	NULL
-277	NULL
«	NULL
169	NULL
homology	NULL
``	NULL
``	NULL
L104	NULL
-73	NULL
-61	NULL
TATA	NULL
27	NULL
+1	NULL
+14	NULL
8	NULL
Ep-	NULL
:	NULL
-L-APq	NULL
~161	NULL
~154	NULL
.	NULL

c-fos	NULL
basal	NULL
AP	NULL
GRE	NULL
CRE	NULL
enhancer	NULL
1	NULL
+1200	NULL
T	NULL
|	NULL
pr	NULL
-1200	NULL
del	NULL
-224	NULL
del	NULL
-181	NULL
del	NULL
-108	NULL
del	NULL
-73	NULL
s	NULL
F	NULL
I-Fig	NULL
.	NULL

1	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
5'-	NULL
del	NULL
-36	NULL
del	NULL
-224/€E	NULL
cis-regulatory	NULL
elements	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
:	NULL
relative	NULL
CAT	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
extended	NULL
map	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
,	NULL
with	NULL
the	NULL
locations	NULL
of	NULL
DNA	NULL
motifs	NULL
known	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
IL-6	NULL
gene	NULL
induction	NULL
by	NULL
various	NULL
inducers	NULL
,	NULL
and	NULL
deletion	NULL
mutants	NULL
of	NULL
del	NULL
-224/Emt	NULL
31	NULL
the	NULL
human	NULL
IL-6	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
B	NULL
promoterless	NULL
CAT	NULL
gene	NULL
.	NULL

B	NULL
,	NULL
to	NULL
assess	NULL
basal	NULL
promoter	NULL
activity	NULL
and	NULL
its	NULL
responsiveness	NULL
to	NULL
IFN-y	NULL
and/or	NULL
and	NULL
to	NULL
LPS	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
tranfected	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
after	NULL
36	NULL
h.	NULL
The	NULL
IL-6	NULL
promoter	NULL
response	NULL
(	NULL
-fold	NULL
induction	NULL
)	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
stimulated	NULL
cells	NULL
to	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
defined	NULL
as	NULL
1.0	NULL
.	NULL

Values	NULL
are	NULL
means	NULL
of	NULL
eight	NULL
independent	NULL
experiments	NULL
with	NULL
standard	NULL
deviation	NULL
less	NULL
than	NULL
10	NULL
%	NULL
.	NULL

Relative	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
and	NULL
cells	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
either	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
or	NULL
with	NULL
LPS	NULL
,	NULL
were	NULL
submitted	NULL
to	NULL
EMSA	NULL
with	NULL
several	NULL
radiolabeled	NULL
double-stranded	NULL
synthetic	NULL
oligonucleotides	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
an	NULL
initial	NULL
experiment	NULL
,	NULL
which	NULL
was	NULL
designed	NULL
to	NULL
screen	NULL
the	NULL
early	NULL
induction	NULL
of	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
an	NULL
EMSA	NULL
using	NULL
five	NULL
different	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
(	NULL
i	NULL
)	NULL
NFxB-like	NULL
and	NULL
AP-1	NULL
binding	NULL
motifs	NULL
(	NULL
A/	NULL
-73	NULL
)	NULL
,	NULL
(	NULL
11	NULL
)	NULL
IL-6-RCE	NULL
(	NULL
RB	NULL
control	NULL
element	NULL
)	NULL
target	NULL
motif	NULL
(	NULL
B/-126	NULL
)	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
the	NULL
typical	NULL
cAMP/phorbol	NULL
ester-responsive	NULL
motif	NULL
,	NULL
and	NULL
the	NULL
IL-1/TNF-	NULL
«	NULL
responsive	NULL
elements	NULL
(	NULL
C/-173	NULL
)	NULL
,	NULL
(	NULL
iv	NULL
)	NULL
the	NULL
negative	NULL
regulatory	NULL
domain-like	NULL
sequence	NULL
(	NULL
and	NULL
two	NULL
putative	NULL
copies	NULL
of	NULL
GGAAA	NULL
motifs	NULL
considered	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
IFN	NULL
inducibility	NULL
(	NULL
D/-207	NULL
)	NULL
,	NULL
and	NULL
(	NULL
v	NULL
)	NULL
the	NULL
consensus	NULL
AP-1	NULL
motif	NULL
and	NULL
a	NULL
copy	NULL
of	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
5'-AAAGGA-3	NULL
'	NULL
(	NULL
E/-283	NULL
)	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Formation	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
apparent	NULL
with	NULL
the	NULL
three	NULL
regions	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
E	NULL
described	NULL
above	NULL
,	NULL
which	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
functional	NULL
response	NULL
of	NULL
the	NULL
5'-flanking	NULL
regions	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
no	NULL
specific	NULL
complexes	NULL
were	NULL
observed	NULL
with	NULL
regions	NULL
C	NULL
and	NULL
D	NULL
,	NULL
previously	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
IL-6	NULL
gene	NULL
regulation	NULL
by	NULL
various	NULL
inducers	NULL
in	NULL
other	NULL
cells	NULL
systems	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
12-16	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Binding	NULL
Activity	NULL
by	NULL
TNF-a	NULL
in	NULL
THP-1	NULL
Cells	NULL
without	NULL
Concomitant	NULL
IL-6	NULL
Production-We	NULL
investigated	NULL
the	NULL
kinetics	NULL
of	NULL
NFKB	NULL
activation	NULL
in	NULL
IFN-y-	NULL
and/or	NULL
TNF-a-treated	NULL
THP-1	NULL
cells	NULL
,	NULL
and	NULL
LPS-treated	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
by	NULL
Control	NULL
IFN-y	NULL
TNF-	NULL
«	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
LPS	NULL
2	NULL
A	NULL
P	NULL
&	NULL
é	NULL
2	NULL
|	NULL
||	NULL
¢	NULL
o	NULL
}	NULL
A	NULL
p	NULL
&	NULL
a	NULL
<	NULL
a	NULL
the	NULL
various	NULL
inducers	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
h	NULL
and	NULL
nuclear	NULL
extracts	NULL
analyzed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
NFxB	NULL
motif	NULL
,	NULL
using	NULL
the	NULL
radiolabeled	NULL
synthetic	NULL
oligonucleotide	NULL
A/-73	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Activated	NULL
complexes	NULL
were	NULL
detectable	NULL
within	NULL
1	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
alone	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
shown	NULL
after	NULL
combined	NULL
treatment	NULL
with	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
after	NULL
treatment	NULL
with	NULL
TNF-	NULL
«	NULL
alone	NULL
.	NULL

The	NULL
abundance	NULL
of	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
TNF-a	NULL
alone	NULL
or	NULL
combined	NULL
with	NULL
IFN-y	NULL
and	NULL
by	NULL
LPS	NULL
increased	NULL
throughout	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
without	NULL
complex	NULL
mobility	NULL
change	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

After	NULL
LPS	NULL
treatment	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
complexes	NULL
increased	NULL
throughout	NULL
4	NULL
h	NULL
of	NULL
stimula-tion	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
TNF-	NULL
«	NULL
either	NULL
alone	NULL
or	NULL
combined	NULL
with	NULL
IFN-y	NULL
,	NULL
led	NULL
to	NULL
a	NULL
transient	NULL
increase	NULL
for	NULL
2	NULL
h	NULL
and	NULL
dramatically	NULL
decreased	NULL
thereafter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
confirmed	NULL
by	NULL
complete	NULL
competition	NULL
of	NULL
the	NULL
binding	NULL
with	NULL
unlabeled	NULL
oligonucleotide	NULL
A/-73	NULL
as	NULL
well	NULL
as	NULL
with	NULL
the	NULL
immunoglobulin	NULL
NFB	NULL
consensus	NULL
motif	NULL
,	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
competition	NULL
with	NULL
AP-1	NULL
or	NULL
SP1	NULL
consensus	NULL
oligomers	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
specific	NULL
binding	NULL
complexes	NULL
in	NULL
untreated	NULL
cells	NULL
or	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
IFN-y	NULL
or	NULL
IFN-a	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
antibodies	NULL
against	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NFxB	NULL
were	NULL
used	NULL
to	NULL
probe	NULL
the	NULL
nuclear	NULL
IL-6-NFxB	NULL
binding	NULL
complexes	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
corresponding	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
antisera	NULL
against	NULL
the	NULL
p65-NFxB	NULL
subunit	NULL
supershifted	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
induced	NULL
by	NULL
TNF-a	NULL
but	NULL
im	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27924	NULL
A	NULL
(	NULL
-73	NULL
)	NULL
B	NULL
(	NULL
126	NULL
)	NULL
IFN-y	NULL
i	NULL
e	NULL
c	NULL
4	NULL
-	NULL
4	NULL
+	NULL
Inducers	NULL
|TNF-	NULL
«	NULL
#	NULL
0080	NULL
400g	NULL
o	NULL
>	NULL
og	NULL
|k	NULL
08	NULL
$	NULL
go	NULL
>	NULL
404	NULL
%	NULL
LPS	NULL
60	NULL
>	NULL
6	NULL
oss	NULL
$	NULL
1	NULL
``	NULL
®	NULL
t	NULL
``	NULL
*	NULL
%	NULL
:	NULL
a	NULL
a	NULL
b	NULL
t	NULL
&	NULL
da	NULL
&	NULL
.	NULL

in	NULL
/~	NULL
Pa	NULL
1	NULL
3	NULL
5	NULL
7	NULL
9	NULL
11	NULL
13	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
C	NULL
(	NULL
173	NULL
)	NULL
D	NULL
(	NULL
-207	NULL
)	NULL
E	NULL
(	NULL
-283	NULL
)	NULL
=o	NULL
#	NULL
o=	NULL
4	NULL
*	NULL
#	NULL
fof	NULL
=o	NULL
¥	NULL
os	NULL
4	NULL
[	NULL
®	NULL
~	NULL
op	NULL
-	NULL
ko	NULL
o	NULL
#	NULL
toot	NULL
®	NULL
of	NULL
=o	NULL
s	NULL
40040	NULL
moog	NULL
fe	NULL
to	NULL
4	NULL
#	NULL
o	NULL
}	NULL
4+	NULL
+	NULL
#	NULL
``	NULL
om	NULL
m	NULL
®	NULL
og	NULL
t	NULL
t	NULL
tot	NULL
*	NULL
&	NULL
ft	NULL
ot	NULL
to	NULL
``	NULL
go	NULL
:	NULL
a	NULL
a	NULL
a	NULL
b	NULL
ah	NULL
#	NULL
an	NULL
im	NULL
Is	NULL
ta	NULL
a*	NULL
w*	NULL
#	NULL
am	NULL
~®	NULL
15	NULL
17	NULL
=	NULL
49	NULL
21	NULL
23	NULL
2500	NULL
27	NULL
29	NULL
0	NULL
31	NULL
14	NULL
-	NULL
16	NULL
18	NULL
20	NULL
22	NULL
4	NULL
0	NULL
26	NULL
28	NULL
30	NULL
°-	NULL
32	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

IFN-y	NULL
and/or	NULL
TNF-a	NULL
,	NULL
and	NULL
LPS	NULL
induce	NULL
binding	NULL
of	NULL
specific	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
gene	NULL
.	NULL

A	NULL
representative	NULL
EMSA	NULL
analysis	NULL
showed	NULL
the	NULL
specific	NULL
binding	NULL
to	NULL
oligonucleotide	NULL
probes	NULL
corresponding	NULL
to	NULL
IL-6	NULL
promoter	NULL
fragments	NULL
:	NULL
A	NULL
,	NULL
-73	NULL
to	NULL
-54	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
;	NULL
B	NULL
,	NULL
-126	NULL
to	NULL
-101	NULL
(	NULL
lanes	NULL
7-13	NULL
)	NULL
,	NULL
C	NULL
,	NULL
-178	NULL
to	NULL
-145	NULL
(	NULL
lanes	NULL
14-19	NULL
)	NULL
;	NULL
D	NULL
,	NULL
-207	NULL
to	NULL
-184	NULL
(	NULL
lanes	NULL
20-25	NULL
)	NULL
;	NULL
E	NULL
,	NULL
-283	NULL
to	NULL
-242	NULL
(	NULL
lanes	NULL
26-32	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
binding	NULL
specificity	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
,	NULL
or	NULL
cells	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
or	NULL
with	NULL
LPS	NULL
,	NULL
were	NULL
compared	NULL
by	NULL
EMSA	NULL
:	NULL
lanes	NULL
1	NULL
,	NULL
7	NULL
,	NULL
14	NULL
,	NULL
20	NULL
,	NULL
and	NULL
26	NULL
,	NULL
untreated	NULL
nuclear	NULL
extracts	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
8	NULL
,	NULL
15	NULL
,	NULL
21	NULL
,	NULL
and	NULL
27	NULL
,	NULL
IFN-y-treated	NULL
nuclear	NULL
extracts	NULL
;	NULL
lanes	NULL
3	NULL
,	NULL
9	NULL
,	NULL
16	NULL
,	NULL
22	NULL
,	NULL
and	NULL
28	NULL
,	NULL
TNF-o-treated	NULL
nuclear	NULL
extracts	NULL
;	NULL
lanes	NULL
4	NULL
,	NULL
10	NULL
,	NULL
17	NULL
,	NULL
23	NULL
,	NULL
and	NULL
29	NULL
,	NULL
IFN-y	NULL
+	NULL
TNF-a-treated	NULL
nuclear	NULL
extracts	NULL
;	NULL
lanes	NULL
5	NULL
,	NULL
11	NULL
,	NULL
18	NULL
,	NULL
24	NULL
,	NULL
and	NULL
30	NULL
,	NULL
LPS-treated	NULL
nuclear	NULL
extracts	NULL
.	NULL

a*	NULL
indicates	NULL
competition	NULL
with	NULL
specific	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
(	NULL
Zanes	NULL
7	NULL
,	NULL
12	NULL
,	NULL
18	NULL
,	NULL
25	NULL
,	NULL
and	NULL
31	NULL
)	NULL
,	NULL
and	NULL
b*	NULL
indicates	NULL
competition	NULL
with	NULL
unlabeled	NULL
unrelated	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
lames	NULL
13	NULL
and	NULL
32	NULL
)	NULL
.	NULL

paired	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

Addition	NULL
of	NULL
antisera	NULL
against	NULL
the	NULL
NFB	NULL
subunit	NULL
p50	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
TNF-	NULL
«	NULL
-induced	NULL
complexes	NULL
,	NULL
but	NULL
those	NULL
induced	NULL
by	NULL
LPS	NULL
were	NULL
partially	NULL
supershifted	NULL
.	NULL

Antibodies	NULL
against	NULL
the	NULL
p52	NULL
and	NULL
c-Rel	NULL
NFxB	NULL
subunits	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
any	NULL
of	NULL
these	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Nevertheless	NULL
,	NULL
combined	NULL
treatment	NULL
with	NULL
antibodies	NULL
against	NULL
p65	NULL
+	NULL
p52	NULL
+	NULL
c-Rel	NULL
NFxB	NULL
subunits	NULL
appeared	NULL
to	NULL
result	NULL
in	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
minor	NULL
residual	NULL
complex	NULL
left	NULL
in	NULL
TNF-a-treated	NULL
cell	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Results	NULL
similar	NULL
to	NULL
those	NULL
shown	NULL
for	NULL
the	NULL
TNF-	NULL
@	NULL
-induced	NULL
complexes	NULL
were	NULL
obtained	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
p65	NULL
is	NULL
contained	NULL
in	NULL
the	NULL
complexes	NULL
,	NULL
whatever	NULL
the	NULL
inducers	NULL
used	NULL
,	NULL
whereas	NULL
p50	NULL
only	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
constituent	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
subunit	NULL
composition	NULL
of	NULL
the	NULL
nuclear	NULL
IL-6-NFxB	NULL
binding	NULL
complexes	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
immuno-precipitated	NULL
with	NULL
specific	NULL
antibodies	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
p65	NULL
subunit-NFB	NULL
was	NULL
found	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-	NULL
«	NULL
alone	NULL
,	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
and	NULL
LPS	NULL
,	NULL
whereas	NULL
antibody	NULL
against	NULL
p50	NULL
only	NULL
revealed	NULL
a	NULL
major	NULL
protein	NULL
of	NULL
50	NULL
kDa	NULL
after	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
stimulation	NULL
by	NULL
combined	NULL
treatment	NULL
with	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
was	NULL
required	NULL
for	NULL
endogenous	NULL
IL-6	NULL
gene	NULL
expression	NULL
and	NULL
protein	NULL
secretion	NULL
,	NULL
and	NULL
that	NULL
TNF-a	NULL
treatment	NULL
alone	NULL
was	NULL
ineffective	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
however	NULL
,	NULL
TNF-a	NULL
was	NULL
effective	NULL
in	NULL
activating	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
NFB-like	NULL
element	NULL
and	NULL
in	NULL
driving	NULL
CAT	NULL
expression	NULL
after	NULL
transfection	NULL
with	NULL
the	NULL
del	NULL
(	NULL
-73	NULL
)	NULL
construct	NULL
containing	NULL
the	NULL
NF	NULL
«	NULL
B-	NULL
like	NULL
sequence	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
repressive	NULL
element	NULL
(	NULL
s	NULL
)	NULL
that	NULL
might	NULL
negatively	NULL
affect	NULL
TNF-o-me-diated	NULL
transcription	NULL
of	NULL
the	NULL
endogenous	NULL
IL-6	NULL
gene	NULL
.	NULL

Involvement	NULL
of	NULL
RCE	NULL
(	NULL
Retinoblastoma	NULL
Control	NULL
Element	NULL
)	NULL
in	NULL
IL-6	NULL
Gene	NULL
Repression	NULL
in	NULL
THP-1	NULL
Cells	NULL
:	NULL
Role	NULL
of	NULL
SP1	NULL
Protein-It	NULL
was	NULL
reported	NULL
that	NULL
Rb	NULL
protein	NULL
but	NULL
not	NULL
its	NULL
mutants	NULL
,	NULL
repress	NULL
IL-6	NULL
promoter	NULL
transcriptional	NULL
activity	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

This	NULL
repression	NULL
was	NULL
mediated	NULL
through	NULL
a	NULL
cis-acting	NULL
element	NULL
,	NULL
first	NULL
described	NULL
in	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
IL-6	NULL
promoter	NULL
contains	NULL
a	NULL
G+C-rich	NULL
sequence	NULL
between	NULL
-126	NULL
and	NULL
-104	NULL
that	NULL
includes	NULL
two	NULL
CCACC	NULL
motifs	NULL
(	NULL
-123	NULL
to	NULL
-118	NULL
and	NULL
-109	NULL
to	NULL
-103	NULL
)	NULL
previously	NULL
identified	NULL
as	NULL
the	NULL
RB	NULL
response	NULL
element	NULL
(	NULL
RCE	NULL
)	NULL
,	NULL
and	NULL
one	NULL
CCGCC	NULL
motif	NULL
similar	NULL
to	NULL
the	NULL
Spl-binding	NULL
site	NULL
(	NULL
-119	NULL
to	NULL
-115	NULL
)	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
suggest	NULL
that	NULL
a	NULL
cis-	NULL
DNA	NULL
element	NULL
,	NULL
which	NULL
is	NULL
located	NULL
between	NULL
-181	NULL
and	NULL
-73	NULL
and	NULL
contains	NULL
,	NULL
among	NULL
others	NULL
,	NULL
the	NULL
RCE	NULL
motifs	NULL
,	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
repression	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
interactions	NULL
between	NULL
proteins	NULL
and	NULL
the	NULL
IL-6-RCE	NULL
sequence	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
stimulated	NULL
with	NULL
various	NULL
inducers	NULL
.	NULL

For	NULL
this	NULL
investigation	NULL
,	NULL
we	NULL
used	NULL
an	NULL
oligonucleotide	NULL
spanning	NULL
both	NULL
sites	NULL
(	NULL
B/-126	NULL
)	NULL
.	NULL

EMSA	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
major	NULL
constitutive	NULL
complex	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
left	NULL
section	NULL
)	NULL
.	NULL

No	NULL
major	NULL
modification	NULL
was	NULL
observed	NULL
after	NULL
this	NULL
stimulation	NULL
.	NULL

Complex	NULL
formation	NULL
was	NULL
specific	NULL
,	NULL
since	NULL
it	NULL
competed	NULL
with	NULL
the	NULL
non-radiolabeled	NULL
specific	NULL
oligonucleotide	NULL
but	NULL
not	NULL
with	NULL
the	NULL
unrelated	NULL
oligonucleotide	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
protein-DNA	NULL
interactions	NULL
appeared	NULL
to	NULL
involve	NULL
the	NULL
Spl	NULL
elements	NULL
,	NULL
since	NULL
binding	NULL
displayed	NULL
complete	NULL
competition	NULL
with	NULL
a	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
A	NULL
LPS	NULL
-	NULL
<	NULL
se	NULL
po	NULL
<	NULL
-	NULL
]	NULL
ex	NULL
e	NULL
e	NULL
-	NULL
go-	NULL
]	NULL
o-	NULL
-	NULL
~	NULL
g	NULL
TNF-C	NULL
--	NULL
#	NULL
#	NULL
-	NULL
clu	NULL
c	NULL
t	NULL
#	NULL
2	NULL
cfl	NULL
ct	NULL
#	NULL
2	NULL
2	NULL
IEN-O	NULL
|	NULL
-	NULL
~	NULL
--	NULL
-	NULL
#	NULL
)	NULL
-	NULL
~	NULL
z	NULL
~	NULL
-	NULL
#	NULL
]	NULL
-	NULL
<	NULL
<	NULL
<	NULL
l~	NULL
+	NULL
[	NULL
FNJY	NULL
moe	NULL
R	NULL
ons	NULL
Ronee	NULL
nud	NULL
ne	NULL
F	NULL
ine	NULL
F	NULL
ser	NULL
mae	NULL
[	NULL
rise	NULL
R	NULL
wen	NULL
R	NULL
ns	NULL
iman	NULL
vittem	NULL
dott	NULL
atts	NULL
Bim	NULL
Ah	NULL
.	NULL

otc	NULL
siles	NULL
Aite	NULL
line	NULL
Ah	NULL
sile	NULL
atis	NULL
2s	NULL
sA	NULL
tic	NULL
,	NULL
Ais	NULL
dili	NULL
t	NULL
n	NULL
5	NULL
&	NULL
1	NULL
hours	NULL
0.5	NULL
|	NULL
1	NULL
[	NULL
2	NULL
Ab	NULL
B	NULL
NFKB	NULL
L126	NULL
s	NULL
``	NULL
l	NULL
NFkB	NULL
Azs	NULL
]	NULL
|	NULL
comp	NULL
.	NULL

-	NULL
-	NULL
730	NULL
AP1	NULL
SP1	NULL
p65	NULL
=	NULL
-73	NULL
-	NULL
AP1	NULL
Ni	NULL
p65	NULL
LAAAAL	NULL
‘	NULL
I-	NULL
‘	NULL
“	NULL
‘	NULL
*	NULL
``	NULL
AF	NULL
“	NULL
M	NULL
M1	NULL
td	NULL
}	NULL
<	NULL
.	NULL

della	NULL
)	NULL
WW	NULL
Rua	NULL
(	NULL
tice	NULL
Nut	NULL
hoth	NULL
heut	NULL
Atl	NULL
hes	NULL
»	NULL
CONT	NULL
]	NULL
TNF-C	NULL
|	NULL
I	NULL
LPS	NULL
|	NULL
C	NULL
IFN	NULL
cont	NULL
IFN	NULL
TNF	NULL
+.YLPS	NULL
(	NULL
$	NULL
3	NULL
)	NULL
IFN-y	NULL
y	NULL
a	NULL
TNF-a	NULL
:	NULL
cont	NULL
|	NULL
4	NULL
I	NULL
LPS	NULL
I	NULL
TNF-	NULL
<	NULL
a	NULL
0	NULL
69g	NULL
*~	NULL
Jp	NULL
-	NULL
sense	NULL
:	NULL
sures	NULL
=a	NULL
«	NULL
to-	NULL
30	NULL
m	NULL
Ab	NULL
I	NULL
against	NULL
p6S	NULL
pso	NULL
'	NULL
N	NULL
!	NULL

Fic	NULL
.	NULL

3	NULL
.	NULL

Kinetics	NULL
of	NULL
induction	NULL
of	NULL
NFxB-binding	NULL
protein	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
and/or	NULL
TNF-	NULL
«	NULL
,	NULL
with	NULL
IFN-a	NULL
,	NULL
or	NULL
with	NULL
LPS	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
after	NULL
cell	NULL
stimulation	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
h.	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
radiolabeled	NULL
oligonucleotide	NULL
A/-73	NULL
.	NULL

B	NULL
,	NULL
specificity	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
cells	NULL
(	NULL
Cont	NULL
)	NULL
or	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
TNF-a	NULL
or	NULL
LPS	NULL
.	NULL

Competition	NULL
studies	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
specific	NULL
oligonucleotides	NULL
A/-73	NULL
(	NULL
-73	NULL
)	NULL
and	NULL
consensus	NULL
NFxB	NULL
,	NULL
or	NULL
with	NULL
unrelated	NULL
oligonucleotides	NULL
AP-1	NULL
,	NULL
B/-126	NULL
(	NULL
-126	NULL
)	NULL
,	NULL
or	NULL
Sp1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
binding	NULL
studies	NULL
including	NULL
antibodies	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
two	NULL
purified	NULL
rabbit	NULL
antisera	NULL
,	NULL
specifically	NULL
reactive	NULL
with	NULL
p50	NULL
or	NULL
p65	NULL
NFkB	NULL
subunits	NULL
(	NULL
Ab	NULL
p50	NULL
,	NULL
p65	NULL
)	NULL
.	NULL

NI	NULL
,	NULL
nonimmune	NULL
antiserum	NULL
added	NULL
for	NULL
nonspecific	NULL
reactions	NULL
.	NULL

C	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
,	NULL
either	NULL
untreated	NULL
(	NULL
Cont	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
various	NULL
inducers	NULL
for	NULL
2	NULL
h	NULL
,	NULL
were	NULL
submitted	NULL
to	NULL
immunoprecipitation	NULL
using	NULL
either	NULL
specific	NULL
antibodies	NULL
against	NULL
p50	NULL
or	NULL
p65	NULL
NFxB	NULL
subunits	NULL
,	NULL
or	NULL
nonimmune	NULL
serum	NULL
.	NULL

After	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
specific	NULL
proteins	NULL
were	NULL
revealed	NULL
with	NULL
the	NULL
corresponding	NULL
antibodies	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Arrows	NULL
point	NULL
to	NULL
specific	NULL
p65	NULL
(	NULL
left	NULL
)	NULL
or	NULL
p50	NULL
(	NULL
right	NULL
)	NULL
NFxB	NULL
subunits	NULL
.	NULL

The	NULL
relative	NULL
mass	NULL
of	NULL
protein	NULL
molecular	NULL
markers	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
middle	NULL
(	NULL
Rainbow	NULL
``	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

Sp1	NULL
consensus	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
purified	NULL
Spl	NULL
protein	NULL
partially	NULL
supershifted	NULL
the	NULL
B/-126	NULL
complex	NULL
,	NULL
whereas	NULL
antibodies	NULL
against	NULL
Rb	NULL
protein	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
addition	NULL
of	NULL
purified	NULL
Sp1	NULL
protein	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
led	NULL
to	NULL
a	NULL
higher	NULL
site	NULL
occupancy	NULL
without	NULL
changing	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
right	NULL
section	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
Sp1	NULL
is	NULL
part	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
with	NULL
B/-126	NULL
oligonucleotide	NULL
.	NULL

This	NULL
oligonucleotide	NULL
,	NULL
which	NULL
encompasses	NULL
the	NULL
RCE-IL-6	NULL
promoter	NULL
element	NULL
,	NULL
includes	NULL
the	NULL
core	NULL
sequence	NULL
5'-CCGCC-3	NULL
'	NULL
(	NULL
-119	NULL
to	NULL
-115	NULL
)	NULL
,	NULL
which	NULL
covers	NULL
part	NULL
of	NULL
the	NULL
RCE	NULL
motif	NULL
(	NULL
-123	NULL
to	NULL
-118	NULL
)	NULL
;	NULL
this	NULL
motif	NULL
appears	NULL
to	NULL
be	NULL
homologous	NULL
with	NULL
the	NULL
5'-CCGCCC-3	NULL
'	NULL
core	NULL
sequence	NULL
,	NULL
reported	NULL
to	NULL
be	NULL
the	NULL
consensus	NULL
binding	NULL
motif	NULL
in	NULL
27925	NULL
volved	NULL
in	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
Sp1	NULL
factor	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
we	NULL
used	NULL
an	NULL
Sp1	NULL
consensus	NULL
oligonucleotide	NULL
as	NULL
the	NULL
radiolabeled	NULL
DNA	NULL
probe	NULL
in	NULL
EMSA	NULL
experiments	NULL
,	NULL
a	NULL
major	NULL
constitutive	NULL
complex	NULL
was	NULL
revealed	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
right	NULL
section	NULL
)	NULL
with	NULL
a	NULL
mobility	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
B/-126	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
left	NULL
section	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
the	NULL
protein-Sp1	NULL
oligonucleotide	NULL
complex	NULL
rose	NULL
slightly	NULL
after	NULL
stimulation	NULL
by	NULL
IFN-y	NULL
,	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
IFN-	NULL
«	NULL
,	NULL
and	NULL
rose	NULL
more	NULL
markedly	NULL
after	NULL
combined	NULL
stimulation	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
.	NULL

Complex	NULL
formation	NULL
was	NULL
impaired	NULL
by	NULL
competition	NULL
with	NULL
the	NULL
specific	NULL
unlabeled	NULL
Sp1	NULL
oligonucleotide	NULL
,	NULL
and	NULL
partial	NULL
competition	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
B/-126	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
antibodies	NULL
against	NULL
the	NULL
Spl	NULL
protein	NULL
led	NULL
to	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
,	NULL
whereas	NULL
no	NULL
effect	NULL
was	NULL
observed	NULL
with	NULL
pRb	NULL
antibodies	NULL
.	NULL

In	NULL
the	NULL
same	NULL
way	NULL
,	NULL
as	NULL
for	NULL
the	NULL
B/-126	NULL
probe	NULL
complex	NULL
,	NULL
addition	NULL
of	NULL
Sp1	NULL
protein	NULL
greatly	NULL
increased	NULL
the	NULL
amount	NULL
of	NULL
protein-DNA	NULL
complex	NULL
revealed	NULL
with	NULL
the	NULL
Sp1	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
Spl	NULL
protein	NULL
in	NULL
the	NULL
B/-126	NULL
DNA	NULL
protein	NULL
complex	NULL
,	NULL
we	NULL
used	NULL
shift-Western	NULL
blot	NULL
analysis	NULL
,	NULL
with	NULL
either	NULL
the	NULL
B/-126	NULL
probe	NULL
or	NULL
the	NULL
Spl	NULL
consensus	NULL
probe	NULL
.	NULL

When	NULL
a	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
the	NULL
B/-126	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A1	NULL
)	NULL
,	NULL
we	NULL
could	NULL
not	NULL
reveal	NULL
the	NULL
presence	NULL
of	NULL
Rb	NULL
protein	NULL
(	NULL
A2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
antibodies	NULL
against	NULL
Sp1	NULL
protein	NULL
recognized	NULL
a	NULL
specific	NULL
protein	NULL
whose	NULL
abundance	NULL
increased	NULL
slightly	NULL
after	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
treatment	NULL
(	NULL
A3	NULL
)	NULL
.	NULL

The	NULL
antibodies	NULL
against	NULL
Rb	NULL
protein	NULL
identified	NULL
a	NULL
faint	NULL
lower	NULL
band	NULL
,	NULL
probably	NULL
corresponding	NULL
to	NULL
free	NULL
Rb	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A2	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
in	NULL
a	NULL
similar	NULL
experiment	NULL
using	NULL
a	NULL
radiolabeled	NULL
Sp1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
antibodies	NULL
against	NULL
Sp1	NULL
protein	NULL
revealed	NULL
a	NULL
specific	NULL
protein	NULL
contained	NULL
in	NULL
the	NULL
protein-DNA	NULL
complex	NULL
(	NULL
B3	NULL
)	NULL
;	NULL
the	NULL
amount	NULL
of	NULL
Sp1	NULL
protein	NULL
correlated	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
probe	NULL
bound	NULL
to	NULL
this	NULL
complex	NULL
(	NULL
B1	NULL
)	NULL
,	NULL
which	NULL
increased	NULL
after	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
treatment	NULL
(	NULL
B3	NULL
)	NULL
.	NULL

A	NULL
faint	NULL
lower	NULL
band	NULL
was	NULL
also	NULL
seen	NULL
,	NULL
probably	NULL
corresponding	NULL
to	NULL
free	NULL
Spl	NULL
protein	NULL
.	NULL

With	NULL
pRb	NULL
antibodies	NULL
,	NULL
no	NULL
protein	NULL
was	NULL
revealed	NULL
in	NULL
the	NULL
protein-DNA	NULL
complex	NULL
,	NULL
and	NULL
as	NULL
in	NULL
the	NULL
experiment	NULL
using	NULL
the	NULL
B/-126	NULL
probe	NULL
,	NULL
a	NULL
lower	NULL
band	NULL
was	NULL
detected	NULL
,	NULL
corresponding	NULL
to	NULL
free	NULL
Rb	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
B2	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
crude	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
alone	NULL
or	NULL
combined	NULL
to	NULL
TNF-a	NULL
,	NULL
using	NULL
antibodies	NULL
against	NULL
Sp1	NULL
protein	NULL
,	NULL
dramatically	NULL
raised	NULL
the	NULL
level	NULL
of	NULL
the	NULL
95-kDa	NULL
native	NULL
Sp1	NULL
protein	NULL
as	NULL
shown	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
upper	NULL
section	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
or	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
«	NULL
correlated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
Sp1	NULL
protein	NULL
,	NULL
the	NULL
same	NULL
immuno-Western	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
monoclonal	NULL
anti-phosphoserine	NULL
antibody	NULL
.	NULL

Fig	NULL
.	NULL

4D	NULL
(	NULL
lower	NULL
section	NULL
)	NULL
shows	NULL
an	NULL
increase	NULL
in	NULL
phosphorylated	NULL
Sp1	NULL
protein	NULL
,	NULL
previously	NULL
reported	NULL
to	NULL
be	NULL
the	NULL
active	NULL
form	NULL
of	NULL
this	NULL
nuclear	NULL
factor	NULL
(	NULL
36	NULL
)	NULL
.	NULL

These	NULL
results	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
increase	NULL
in	NULL
binding	NULL
activity	NULL
shown	NULL
by	NULL
EMSA	NULL
performed	NULL
with	NULL
the	NULL
Sp1	NULL
probe	NULL
after	NULL
THP-1	NULL
cell	NULL
treatment	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
right	NULL
section	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Sp1	NULL
protein	NULL
in	NULL
the	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
the	NULL
RCE	NULL
present	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
.	NULL

Although	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
RCE-IL-6	NULL
promoter	NULL
,	NULL
shift-	NULL
Western	NULL
blot	NULL
and	NULL
antibody-supershift	NULL
experiments	NULL
nevertheless	NULL
suggest	NULL
that	NULL
Spl	NULL
is	NULL
part	NULL
of	NULL
the	NULL
activity	NULL
that	NULL
interacts	NULL
with	NULL
this	NULL
region	NULL
.	NULL

Regulation	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF	NULL
-2	NULL
in	NULL
the	NULL
Synergistic	NULL
Induction	NULL
of	NULL
IL-6	NULL
Gene	NULL
Expression	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-o-Functional	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
showed	NULL
that	NULL
a	NULL
distal	NULL
element	NULL
between	NULL
-1200	NULL
and	NULL
-224	NULL
regulates	NULL
positively	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
alone	NULL
,	NULL
or	NULL
combined	NULL
with	NULL
TNF-a	NULL
.	NULL

EMSA	NULL
using	NULL
probe	NULL
E/-283	NULL
,	NULL
and	NULL
encompassing	NULL
a	NULL
copy	NULL
of	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
,	NULL
revealed	NULL
the	NULL
formation	NULL
of	NULL
2	NULL
protein-DNA	NULL
complexes	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
specifically	NULL
induced	NULL
by	NULL
IFN-y	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
kinetics	NULL
of	NULL
complex	NULL
activation	NULL
in	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27926	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
A	NULL
B	NULL
LP§	NULL
=_	NULL
_	NULL
--	NULL
-	NULL
$	NULL
-	NULL
Ab	NULL
Ab	NULL
_	NULL
|	NULL
--	NULL
TNE-L	NULL
=	NULL
--	NULL
4	NULL
+	NULL
--	NULL
--	NULL
++	NULL
--	NULL
aP1	NULL
(	NULL
ro	NULL
10	NULL
Rp	NULL
|	NULL
ree	NULL
.	NULL

SP1	NULL
IFN	NULL
-	NULL
--	NULL
--	NULL
-	NULL
$	NULL
~~~	NULL
+	NULL
--	NULL
126	NULL
-	NULL
SP1	NULL
-	NULL
Sp1	NULL
-	NULL
-	NULL
Spi	NULL
protein	NULL
IFN-Y	NULL
=	NULL
-+-	NULL
4-~	NULL
-+-+	NULL
--	NULL
4	NULL
sa	NULL
a	NULL
4	NULL
a	NULL
A	NULL
4	NULL
t	NULL
***	NULL
~*	NULL
]	NULL
44	NULL
4	NULL
dusk	NULL
bud	NULL
=	NULL
bubs	NULL
s	NULL
tM	NULL
|	NULL
s	NULL
W	NULL
cont	NULL
inay	NULL
-	NULL
CFW	NULL
Y	NULL
proBEs	NULL
|	NULL
-126	NULL
sp	NULL
c	NULL
A	NULL
``	NULL
elige	NULL
sP1	NULL
|	NULL
H	NULL
l	NULL
p	NULL
Mr	NULL
(	NULL
kDa	NULL
)	NULL
protein	NULL
IN	NULL
!	NULL

_	NULL
Rb	NULL
sP1	NULL
126	NULL
SP1	NULL
£3	NULL
Deo	NULL
ee	NULL
ee	NULL
CBP	NULL
-a	NULL
92.5	NULL
1	NULL
t	NULL
-=	NULL
``	NULL
if	NULL
im	NULL
<	NULL
outh	NULL
b	NULL
MM	NULL
A	NULL
IFN-cont	NULL
IFN	NULL
+l	NULL
y	NULL
TNFOL	NULL
-	NULL
~	NULL
#	NULL
]	NULL
-|-	NULL
2	NULL
#	NULL
]	NULL
-	NULL
°	NULL
#	NULL
|	NULL
.	NULL

s	NULL
4+|-TNF	NULL
L	NULL
95	NULL
1	NULL
MX	NULL
(	NULL
ike	NULL
me	NULL
IFN-Y¥	NULL
|	NULL
-+	NULL
4+	NULL
4	NULL
|-	NULL
4+	NULL
4+	NULL
|-	NULL
4	NULL
%	NULL
4+	NULL
]	NULL
kDa	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Specificity	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
RB	NULL
control	NULL
elements	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
,	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
0.5	NULL
h	NULL
with	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
IFN-a	NULL
,	NULL
using	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
B/-	NULL
126	NULL
(	NULL
left	NULL
section	NULL
)	NULL
,	NULL
or	NULL
radiolabeled	NULL
consensus	NULL
Sp1	NULL
oligonucleotide	NULL
(	NULL
right	NULL
section	NULL
)	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
left	NULL
untreated	NULL
for	NULL
0.5	NULL
h	NULL
(	NULL
Cont	NULL
)	NULL
were	NULL
submitted	NULL
to	NULL
EMSA	NULL
using	NULL
the	NULL
B/-126	NULL
radiolabeled	NULL
probe	NULL
to	NULL
reveal	NULL
specific	NULL
competition	NULL
between	NULL
RCE-binding	NULL
proteins	NULL
and	NULL
either	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
B/-126	NULL
or	NULL
Sp1	NULL
consensus	NULL
oligonucleotide	NULL
.	NULL

AP-1	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
unrelated	NULL
competitor	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
untreated	NULL
cells	NULL
(	NULL
Cont	NULL
)	NULL
or	NULL
IFN-y-treated	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
antibodies	NULL
(	NULL
A5	NULL
)	NULL
against	NULL
Rb	NULL
protein	NULL
(	NULL
Rb	NULL
)	NULL
or	NULL
against	NULL
Sp1	NULL
protein	NULL
(	NULL
Sp1	NULL
)	NULL
,	NULL
and	NULL
radiolabeled	NULL
probe	NULL
B/-126	NULL
was	NULL
then	NULL
added	NULL
.	NULL

Recombinant	NULL
Sp1	NULL
protein	NULL
(	NULL
1.0	NULL
footprinting	NULL
units	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
nuclear	NULL
extract	NULL
of	NULL
untreated	NULL
cells	NULL
(	NULL
Cont	NULL
)	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
,	NULL
and	NULL
radiolabeled	NULL
B/-126	NULL
probe	NULL
was	NULL
then	NULL
added	NULL
(	NULL
right	NULL
section	NULL
)	NULL
.	NULL

C	NULL
,	NULL
specifity	NULL
of	NULL
the	NULL
EMSA	NULL
complexes	NULL
revealed	NULL
with	NULL
radiolabeled	NULL
probe	NULL
Sp1	NULL
.	NULL

Before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
Sp1	NULL
oligonucleotide	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
untreated	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
were	NULL
mixed	NULL
either	NULL
with	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
-126	NULL
,	NULL
Sp1	NULL
)	NULL
,	NULL
or	NULL
with	NULL
antibodies	NULL
(	NULL
A5	NULL
)	NULL
against	NULL
Sp1	NULL
protein	NULL
or	NULL
Rb	NULL
protein	NULL
;	NULL
NZ	NULL
corresponded	NULL
to	NULL
nonimmune	NULL
rabbit	NULL
antiserum	NULL
.	NULL

Sp1	NULL
protein	NULL
(	NULL
1.0	NULL
footprinting	NULL
unit	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
.	NULL

D	NULL
,	NULL
immunoprecipitation	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
Con	NULL
#	NULL
)	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
alone	NULL
or	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
@	NULL
,	NULL
using	NULL
antibodies	NULL
against	NULL
Sp1	NULL
protein	NULL
,	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Upper	NULL
part	NULL
shows	NULL
blot	NULL
hybridization	NULL
with	NULL
Sp1	NULL
antibodies	NULL
.	NULL

Lower	NULL
part	NULL
,	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
dehybridized	NULL
and	NULL
reprobed	NULL
with	NULL
antibodies	NULL
against	NULL
phosphoserine	NULL
protein	NULL
.	NULL

Left	NULL
arrows	NULL
point	NULL
to	NULL
the	NULL
specific	NULL
Sp1	NULL
protein	NULL
.	NULL

Right	NULL
arrows	NULL
(	NULL
mass	NULL
in	NULL
kDa	NULL
)	NULL
point	NULL
to	NULL
the	NULL
relative	NULL
mass	NULL
of	NULL
protein	NULL
molecular	NULL
markers	NULL
.	NULL

A	NULL
Probe	NULL
B/-126	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Spl	NULL
protein	NULL
is	NULL
part	NULL
of	NULL
IL-6-RCE-protein	NULL
complex	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
either	NULL
the	NULL
radiolabeled	NULL
B/-126	NULL
oligonucleotide	NULL
(	NULL
4	NULL
)	NULL
or	NULL
the	NULL
radiolabeled	NULL
Sp1	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Shift-Western	NULL
blot	NULL
analysis	NULL
was	NULL
then	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Radiolabeled	NULL
DNA	NULL
was	NULL
visualized	NULL
on	NULL
DEAE	NULL
membrane	NULL
(	NULL
A1	NULL
and	NULL
B1	NULL
)	NULL
whereas	NULL
either	NULL
Rb	NULL
protein	NULL
(	NULL
A2	NULL
and	NULL
B2	NULL
)	NULL
or	NULL
B	NULL
Probe	NULL
Sp1	NULL
protein	NULL
(	NULL
A3	NULL
and	NULL
B3	NULL
)	NULL
was	NULL
revealed	NULL
on	NULL
SP	NULL
nitrocellulose	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
respective	NULL
specific	NULL
antibodies	NULL
against	NULL
Rb	NULL
protein	NULL
and	NULL
Sp1	NULL
protein	NULL
.	NULL

and/or	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
IFN-	NULL
«	NULL
.	NULL

The	NULL
same	NULL
nuclear	NULL
extracts	NULL
as	NULL
those	NULL
already	NULL
used	NULL
for	NULL
the	NULL
NFB	NULL
experiments	NULL
were	NULL
analyzed	NULL
for	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
IFN-enhancer	NULL
motif	NULL
,	NULL
using	NULL
probe	NULL
E/-283	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
,	NULL
EMSA	NULL
revealed	NULL
the	NULL
pres	NULL
&	NULL
$	NULL
#	NULL
4	NULL
Laut	NULL
.x	NULL
``	NULL
SagA-q	NULL
ad	NULL
ale	NULL
&	NULL
3	NULL
©4	NULL
&	NULL
Al	NULL
=	NULL
Ac	NULL
Rb	NULL
Ac	NULL
SP-1	NULL
``	NULL
B2	NULL
B3	NULL
DNA	NULL
Western-blot	NULL
ence	NULL
of	NULL
a	NULL
constitutive	NULL
DNA-protein	NULL
complex	NULL
,	NULL
C1	NULL
whose	NULL
amount	NULL
increased	NULL
in	NULL
a	NULL
time-dependent	NULL
manner	NULL
after	NULL
stimulation	NULL
by	NULL
IFN-y	NULL
and	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
this	NULL
C1	NULL
complex	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
IFN-a	NULL
.	NULL

Note	NULL
that	NULL
,	NULL
IFN-y	NULL
alone	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
A	NULL
LP§	NULL
==	NULL
--	NULL
-	NULL
-¥	NULL
<	NULL
]	NULL
$	NULL
m	NULL
|	NULL
me	NULL
#	NULL
p	NULL
me	NULL
TNF-O	NULL
_-_	NULL
#	NULL
#	NULL
_-	NULL
«	NULL
-	NULL
]	NULL
_	NULL
-	NULL
#	NULL
#	NULL
k	NULL
#	NULL
c-IFN-Q	NULL
=-	NULL
--	NULL
--	NULL
4	NULL
]	NULL
-	NULL
-	NULL
--	NULL
-	NULL
#	NULL
]	NULL
-	NULL
-	NULL
--	NULL
-	NULL
+	NULL
IFNf	NULL
|	NULL
_	NULL
#	NULL
_	NULL
¥	NULL
2	NULL
ol	NULL
2	NULL
t	NULL
ack	NULL
e	NULL
|e	NULL
t	NULL
ot	NULL
_	NULL
_-tool	NULL
bnink	NULL
98	NULL
Hat	NULL
Sic	NULL
fun	NULL
sc	NULL
tru	NULL
os	NULL
a	NULL
Go	NULL
ge	NULL
)	NULL
sa	NULL
Rpt	NULL
to	NULL
(	NULL
A0	NULL
``	NULL
9	NULL
C1	NULL
=	NULL
C2	NULL
B	NULL
IFN-Y	NULL
+	NULL
TNF-	NULL
IFN-Y	NULL
+	NULL
TNF-sf	NULL
~	NULL
1	NULL
-f-	NULL
1	NULL
CAi	NULL
~	NULL
>	NULL
aut	NULL
baud	NULL
dour	NULL
Roath	NULL
Sout	NULL
bsd	NULL
he	NULL
C2m	NULL
fmumﬁum	NULL
$	NULL
t	NULL
:	NULL
~	NULL
ﬂgﬁRﬁ	NULL
a	NULL
=	NULL
=	NULL
AP1	NULL
=	NULL
>	NULL
antibodie	NULL
competitor	NULL
.za	NULL
:	NULL
;	NULL
1	NULL
5mt3	NULL
4	NULL
Aizs	NULL
IRE2	NULL
N	NULL
!	NULL

against	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
and	NULL
specificity	NULL
of	NULL
IFN-y	NULL
regulated	NULL
IRF-1/	NULL
IRF-2	NULL
complexes	NULL
.	NULL

Radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
E/-283	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
.	NULL

A	NULL
,	NULL
binding	NULL
reactions	NULL
were	NULL
tested	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
various	NULL
inducers	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
h.	NULL
Arrows	NULL
indicate	NULL
C1-	NULL
and	NULL
C2-specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
two	NULL
complexes	NULL
by	NULL
means	NULL
of	NULL
the	NULL
following	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
:	NULL
E/-283	NULL
without	NULL
mutation	NULL
(	NULL
-283	NULL
)	NULL
,	NULL
or	NULL
with	NULL
mutation	NULL
(	NULL
mt	NULL
)	NULL
in	NULL
the	NULL
AP-1	NULL
motif	NULL
(	NULL
mt	NULL
15	NULL
)	NULL
or	NULL
in	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
(	NULL
mt	NULL
31	NULL
)	NULL
,	NULL
ISRE	NULL
,	NULL
and	NULL
C3	NULL
.	NULL

Oligonucleotides	NULL
AP-1	NULL
,	NULL
B/-126	NULL
(	NULL
-126	NULL
)	NULL
and	NULL
Sp1	NULL
were	NULL
used	NULL
as	NULL
nonspecific	NULL
competitors	NULL
.	NULL

C	NULL
,	NULL
before	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
E/-283	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
for	NULL
2	NULL
h	NULL
were	NULL
preincubated	NULL
with	NULL
antibodies	NULL
against	NULL
IRF-2	NULL
,	NULL
IRF-1	NULL
,	NULL
or	NULL
nonimmune	NULL
antiserum	NULL
(	NULL
NZ	NULL
)	NULL
.	NULL

induced	NULL
a	NULL
second	NULL
protein-DNA	NULL
complex	NULL
(	NULL
C2	NULL
)	NULL
,	NULL
which	NULL
was	NULL
not	NULL
observed	NULL
after	NULL
TNF-a	NULL
or	NULL
LPS	NULL
stimulation	NULL
.	NULL

EMSA	NULL
carried	NULL
out	NULL
with	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
IFN-a	NULL
«	NULL
for	NULL
2	NULL
h	NULL
revealed	NULL
a	NULL
faint	NULL
C2	NULL
complex	NULL
.	NULL

To	NULL
define	NULL
the	NULL
sequence	NULL
specificity	NULL
of	NULL
the	NULL
C1	NULL
and	NULL
C2	NULL
complexes	NULL
,	NULL
competition	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
synthetic	NULL
oligonucleotides	NULL
representing	NULL
several	NULL
mutations	NULL
of	NULL
the	NULL
-283	NULL
to	NULL
-242	NULL
region	NULL
either	NULL
in	NULL
the	NULL
putative	NULL
interferon	NULL
enhancer	NULL
core	NULL
sequence	NULL
5'-AAAGG-3	NULL
'	NULL
(	NULL
-283/mt31	NULL
)	NULL
or	NULL
in	NULL
the	NULL
AP1	NULL
motif	NULL
(	NULL
-283/mt15	NULL
)	NULL
,	NULL
and	NULL
also	NULL
with	NULL
the	NULL
ISRE	NULL
of	NULL
the	NULL
2',5'-oligo	NULL
(	NULL
A	NULL
)	NULL
synthetase	NULL
gene	NULL
promoter	NULL
,	NULL
known	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
IFN	NULL
responses	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
with	NULL
the	NULL
C3	NULL
oligonucleotide	NULL
defined	NULL
by	NULL
its	NULL
IRF-1-binding	NULL
activity	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
E/-283	NULL
and	NULL
the	NULL
mutant	NULL
-283/mt15	NULL
competed	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
mt	NULL
15	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
mutant	NULL
-283/mt31	NULL
lost	NULL
this	NULL
capacity	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
mt	NULL
31	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
5'-AAAGG-3	NULL
'	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
DNA-protein	NULL
interaction	NULL
.	NULL

Complete	NULL
competition	NULL
for	NULL
the	NULL
C1	NULL
and	NULL
C2	NULL
complexes	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
ISRE	NULL
and	NULL
C3	NULL
oligonucleotides	NULL
.	NULL

A	NULL
trimer	NULL
AP-1	NULL
motif	NULL
was	NULL
not	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
either	NULL
complex	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
behavior	NULL
of	NULL
mutant	NULL
-283/mt15	NULL
.	NULL

No	NULL
competition	NULL
was	NULL
observed	NULL
neither	NULL
with	NULL
the	NULL
Sp1	NULL
nor	NULL
with	NULL
B/-126	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
possible	NULL
relationship	NULL
between	NULL
the	NULL
C1	NULL
and	NULL
C2	NULL
complexes	NULL
and	NULL
ISGF3	NULL
(	NULL
25-27	NULL
,	NULL
47	NULL
)	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
IFN-a	NULL
@	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
binding	NULL
activity	NULL
,	NULL
using	NULL
the	NULL
E/-283	NULL
,	NULL
ISRE	NULL
,	NULL
or	NULL
C3	NULL
oligonucleotides	NULL
as	NULL
DNA	NULL
radiolabeled	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
very	NULL
similar	NULL
with	NULL
the	NULL
E/-283	NULL
and	NULL
C3	NULL
oligonucleotide	NULL
probes	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
bind	NULL
the	NULL
IRF-l-related	NULL
factor	NULL
.	NULL

For	NULL
ISRE-DNA-protein	NULL
binding	NULL
,	NULL
only	NULL
IFN-a	NULL
treatment	NULL
resulted	NULL
in	NULL
a	NULL
double	NULL
upper-induced	NULL
binding	NULL
activity	NULL
27927	NULL
LPS	NULL
somers	NULL
sep	NULL
m	NULL
-o-	NULL
=	NULL
mq	NULL
o-	NULL
omo	NULL
-	NULL
=	NULL
g	NULL
TNF-Q	NULL
-	NULL
-	NULL
#	NULL
4+	NULL
.	NULL

_	NULL
son	NULL
#	NULL
$	NULL
.	NULL

2	NULL
Lon	NULL
#	NULL
40202	NULL
IFN-y	NULL
Log	NULL
2	NULL
4	NULL
202	NULL
_o	NULL
¥	NULL
2	NULL
4	NULL
0202	NULL
Lops	NULL
FNG	NULL
\	NULL
=m	NULL
w	NULL
aunt	NULL
00	NULL
some	NULL
som	NULL
#	NULL
m	NULL
me	NULL
as	NULL
cas	NULL
an	NULL
#	NULL
bulbs	NULL
-s	NULL
-a	NULL
pede	NULL
DNA	NULL
PRoBES	NULL
E/-283	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

E/-283	NULL
,	NULL
CS-radiolabeled	NULL
oligonucleotides	NULL
,	NULL
and	NULL
ISRE	NULL
:	NULL
-radiolabeled	NULL
oligonucleotide	NULL
gave	NULL
different	NULL
patterns	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
IFN-y	NULL
,	NULL
TNF-a	NULL
,	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
IFN-	NULL
«	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
binding	NULL
activity	NULL
,	NULL
using	NULL
oligonucleotides	NULL
radiolabeled	NULL
with	NULL
E/-283	NULL
(	NULL
eft	NULL
section	NULL
)	NULL
,	NULL
C3	NULL
(	NULL
middle	NULL
section	NULL
)	NULL
,	NULL
or	NULL
ISRE	NULL
(	NULL
right	NULL
section	NULL
)	NULL
.	NULL

Double	NULL
arrows	NULL
indicate	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

ISRE	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
;	NULL
several	NULL
constitutive	NULL
complexes	NULL
showed	NULL
no	NULL
quantitative	NULL
or	NULL
qualitative	NULL
changes	NULL
,	NULL
whatever	NULL
the	NULL
inducers	NULL
used	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
C1	NULL
and	NULL
C2	NULL
complexes	NULL
did	NULL
not	NULL
involve	NULL
ISGF3	NULL
,	NULL
but	NULL
rather	NULL
IRF-1/IRF-2	NULL
,	NULL
unlike	NULL
the	NULL
IFN-	NULL
@	NULL
-induced	NULL
complexes	NULL
revealed	NULL
with	NULL
the	NULL
ISRE	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
constitutive	NULL
DNA-binding	NULL
C1	NULL
complex	NULL
was	NULL
markedly	NULL
reduced	NULL
by	NULL
the	NULL
IRF	NULL
-2	NULL
antibodies	NULL
,	NULL
while	NULL
the	NULL
inducible	NULL
complex	NULL
C2	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
IRF-1	NULL
antibodies	NULL
.	NULL

The	NULL
IRF-1	NULL
antibodies	NULL
also	NULL
abolished	NULL
the	NULL
time-dependent	NULL
increase	NULL
in	NULL
the	NULL
C1	NULL
complex	NULL
,	NULL
which	NULL
remained	NULL
at	NULL
its	NULL
constitutive	NULL
level	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
IRF-2	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
constitutive	NULL
C1	NULL
complex	NULL
,	NULL
and	NULL
that	NULL
IRF-1	NULL
is	NULL
involved	NULL
both	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
inducible	NULL
C2	NULL
complex	NULL
and	NULL
in	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
C1	NULL
complex	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
this	NULL
typical	NULL
IRF	NULL
recognition	NULL
sequence	NULL
is	NULL
sufficient	NULL
for	NULL
IFN-y	NULL
activation	NULL
and	NULL
for	NULL
the	NULL
synergistic	NULL
action	NULL
of	NULL
IFN-y	NULL
with	NULL
TNF-a	NULL
«	NULL
,	NULL
we	NULL
constructed	NULL
mutated	NULL
IL-6	NULL
promoter	NULL
CAT	NULL
expression	NULL
plasmids	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
linked	NULL
oligonucleotide	NULL
E/-283	NULL
,	NULL
or	NULL
oligonucleotide	NULL
-283/mt31	NULL
,	NULL
which	NULL
carried	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
putative	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
AAAGGA	NULL
(	NULL
-253	NULL
to	NULL
-248	NULL
)	NULL
,	NULL
to	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
-CAT	NULL
and	NULL
called	NULL
the	NULL
resulting	NULL
constructs	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/E	NULL
and	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/Emt31	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
the	NULL
relative	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
after	NULL
THP-1	NULL
transfection	NULL
with	NULL
construct	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/E	NULL
demonstrated	NULL
that	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
responsiveness	NULL
to	NULL
IFN-y	NULL
,	NULL
because	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
AAAGGA	NULL
motif	NULL
(	NULL
see	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/Emt31	NULL
)	NULL
abolished	NULL
IFN-y	NULL
sensi-tivity	NULL
;	NULL
the	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
synergistic	NULL
induction	NULL
was	NULL
preserved	NULL
,	NULL
although	NULL
to	NULL
a	NULL
much	NULL
smaller	NULL
extent	NULL
(	NULL
2-fold	NULL
induction	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
,	NULL
surrounding	NULL
sequences	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
IFN-y	NULL
with	NULL
TNF-a	NULL
.	NULL

Transfection	NULL
of	NULL
either	NULL
of	NULL
the	NULL
constructs	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/E	NULL
or	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/mt31	NULL
resulted	NULL
in	NULL
a	NULL
similar	NULL
LPS-induced	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
(	NULL
7-	NULL
and	NULL
6-fold	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
IFN	NULL
enhancer	NULL
core	NULL
sequence	NULL
did	NULL
not	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
LPS	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
LPS	NULL
inducibility	NULL
required	NULL
the	NULL
cooperation	NULL
of	NULL
other	NULL
(	NULL
s	NULL
)	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
progressive	NULL
reduction	NULL
of	NULL
CAT	NULL
activity	NULL
after	NULL
the	NULL
transfection	NULL
of	NULL
IL-6	NULL
promoter	NULL
5	NULL
'	NULL
end	NULL
successive	NULL
deletions	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
and	NULL
LPS	NULL
induced	NULL
the	NULL
IL-6	NULL
gene	NULL
by	NULL
different	NULL
pathways	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27928	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
A	NULL
IFN-¥	NULL
cont	NULL
N	NULL
NF	NULL
%	NULL
'	NULL
ups	NULL
”	NULL
if	NULL
*	NULL
NPG	NULL
42	NULL
kDa	NULL
Im	NULL
am	NULL
eels	NULL
.	NULL

30	NULL
min	NULL
IFN-y	NULL
TNF	NULL
IFN	NULL
u	NULL
I	NULL
I	NULL
-__	NULL
I	NULL
I	NULL
BONT	NULL
z	NULL
HP®	NULL
vy	NULL
swfig	NULL
-a	NULL
_	NULL
55	NULL
kDa	NULL
m	NULL
vides	NULL
h	NULL
m	NULL
``	NULL
w	NULL
ess	NULL
2	NULL
kD	NULL
me	NULL
:	NULL
coins	NULL
#	NULL
4	NULL
42	NULL
kDa	NULL
«	NULL
uses	NULL
-f	NULL
42kDa	NULL
dint	NULL
``	NULL
30	NULL
kDa	NULL
p-IRF-2	NULL
``	NULL
x	NULL
__	NULL
2	NULL
hours	NULL
_¥	NULL
IRF	NULL
in-B	NULL
cONT	NULL
ien	NULL
our	NULL
4C	NULL
urs	NULL
irn	NULL
42	NULL
kDa	NULL
*~	NULL
IRF-2	NULL
Wie	NULL
-	NULL
H0	NULL
,	NULL
agl	NULL
30	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Modulation	NULL
of	NULL
IRF-1	NULL
or	NULL
IRF-2	NULL
proteins	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
of	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
CONT	NULL
)	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
various	NULL
inducers	NULL
for	NULL
30	NULL
min	NULL
(	NULL
upper	NULL
section	NULL
)	NULL
or	NULL
for	NULL
2	NULL
h	NULL
(	NULL
lower	NULL
section	NULL
)	NULL
were	NULL
submitted	NULL
to	NULL
immunoprecipitation	NULL
using	NULL
specific	NULL
antibodies	NULL
against	NULL
IRF-1	NULL
or	NULL
IRF-2	NULL
,	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

IRF-2	NULL
protein	NULL
was	NULL
analyzed	NULL
after	NULL
treatment	NULL
of	NULL
THP-1	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
or	NULL
2	NULL
h	NULL
by	NULL
various	NULL
inducers	NULL
,	NULL
whereas	NULL
IRF-1	NULL
protein	NULL
was	NULL
analyzed	NULL
after	NULL
cell	NULL
stimulation	NULL
for	NULL
2	NULL
h.	NULL
Middle	NULL
arrows	NULL
indicate	NULL
the	NULL
relative	NULL
mass	NULL
of	NULL
protein	NULL
molecular	NULL
weight	NULL
markers	NULL
.	NULL

Left	NULL
or	NULL
right	NULL
external	NULL
arrows	NULL
indicate	NULL
specific	NULL
IRF-2	NULL
or	NULL
IRF-1	NULL
proteins	NULL
.	NULL

B	NULL
,	NULL
in	NULL
vitro	NULL
translation	NULL
:	NULL
total	NULL
RNAs	NULL
were	NULL
extracted	NULL
from	NULL
cells	NULL
left	NULL
untreated	NULL
for	NULL
2	NULL
h	NULL
(	NULL
Cont	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
,	NULL
and	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
480	NULL
ug	NULL
total	NULL
RNA/m	NULL
!	NULL

,	NULL
using	NULL
reticulocyte	NULL
lysate	NULL
and	NULL
under	NULL
defined	NULL
optimal	NULL
conditions	NULL
(	NULL
97	NULL
mM	NULL
KCl	NULL
and	NULL
1.8	NULL
mm	NULL
Mg	NULL
(	NULL
CH	NULL
,	NULL
COO	NULL
)	NULL
;	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
of	NULL
1	NULL
h	NULL
at	NULL
32	NULL
°C	NULL
,	NULL
volume	NULL
aliquots	NULL
corresponding	NULL
to	NULL
5	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
labeled	NULL
polypeptides	NULL
were	NULL
submitted	NULL
to	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Differential	NULL
Regulation	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
Expression	NULL
by	NULL
IFN-y	NULL
or	NULL
LPS-Previous	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
factors	NULL
display	NULL
antagonist	NULL
activities	NULL
,	NULL
and	NULL
that	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
one	NULL
factor	NULL
results	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
other	NULL
(	NULL
28-32	NULL
)	NULL
.	NULL

Our	NULL
demonstration	NULL
that	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
correlated	NULL
with	NULL
the	NULL
synergistic	NULL
induction	NULL
of	NULL
IL-6	NULL
promoter	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
prompted	NULL
us	NULL
to	NULL
compare	NULL
the	NULL
regulation	NULL
of	NULL
IRF-1/IRF-2	NULL
by	NULL
IFN-y	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
with	NULL
their	NULL
regulation	NULL
by	NULL
IFN-	NULL
«	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
immuno-Western	NULL
blot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
after	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
was	NULL
performed	NULL
using	NULL
antibodies	NULL
against	NULL
IRF-1	NULL
or	NULL
IRF-2	NULL
.	NULL

A	NULL
polypeptide	NULL
of	NULL
42	NULL
kDa	NULL
was	NULL
revealed	NULL
by	NULL
the	NULL
IRF-1	NULL
antibodies	NULL
,	NULL
but	NULL
only	NULL
after	NULL
stimulation	NULL
by	NULL
IFN-y	NULL
or	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
right	NULL
section	NULL
)	NULL
.	NULL

The	NULL
IRF-2	NULL
antibodies	NULL
detected	NULL
a	NULL
constitutive	NULL
IRF-2	NULL
protein	NULL
whose	NULL
abundance	NULL
was	NULL
not	NULL
modified	NULL
after	NULL
cell	NULL
treatment	NULL
with	NULL
IFN-y	NULL
or	NULL
TNF-a	NULL
either	NULL
alone	NULL
or	NULL
combined	NULL
for	NULL
2	NULL
h.	NULL
In	NULL
contrast	NULL
,	NULL
treatment	NULL
with	NULL
LPS	NULL
or	NULL
IFN-	NULL
«	NULL
reduced	NULL
the	NULL
amount	NULL
of	NULL
IRF-2	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
left	NULL
section	NULL
)	NULL
.	NULL

Since	NULL
formation	NULL
of	NULL
the	NULL
constitutive	NULL
C1	NULL
complex	NULL
involved	NULL
IRF-2	NULL
protein	NULL
binding	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
establish	NULL
whether	NULL
a	NULL
transient	NULL
modulation	NULL
of	NULL
this	NULL
protein	NULL
occurred	NULL
soon	NULL
after	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
(	NULL
left	NULL
section	NULL
)	NULL
,	NULL
treatment	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
IFN-	NULL
«	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
IRF-2	NULL
protein	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
TNF-a	NULL
was	NULL
transient	NULL
,	NULL
because	NULL
the	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
IRF-2	NULL
protein	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
for	NULL
2	NULL
h.	NULL
In	NULL
contrast	NULL
,	NULL
the	NULL
inhibition	NULL
by	NULL
IFN-a	NULL
or	NULL
LPS	NULL
of	NULL
the	NULL
IRF-2	NULL
protein	NULL
level	NULL
lasted	NULL
throughout	NULL
the	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

Since	NULL
the	NULL
amount	NULL
of	NULL
IRF-2	NULL
protein	NULL
diminished	NULL
after	NULL
cell	NULL
stimulation	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
IFN-a	NULL
,	NULL
whereas	NULL
IRF-1	NULL
protein	NULL
was	NULL
only	NULL
induced	NULL
by	NULL
IFN-y	NULL
,	NULL
we	NULL
explored	NULL
this	NULL
effect	NULL
to	NULL
see	NULL
if	NULL
it	NULL
was	NULL
related	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
IRF-1	NULL
and	NULL
(	NULL
or	NULL
)	NULL
a	NULL
decrease	NULL
in	NULL
IRF-2	NULL
gene	NULL
expressions	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
total	NULL
RNAs	NULL
were	NULL
extracted	NULL
after	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
h	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
various	NULL
inducers	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

LP§	NULL
$	NULL
0	NULL
-	NULL
-	NULL
-	NULL
-	NULL
=-	NULL
=-TNF-C	NULL
=	NULL
o-	NULL
#	NULL
#	NULL
&	NULL
«	NULL
|e	NULL
&	NULL
40	NULL
$	NULL
0	NULL
&	NULL
e	NULL
|k	NULL
s	NULL
#	NULL
040	NULL
kok	NULL
IFN-Y	NULL
=o	NULL
+	NULL
4	NULL
+	NULL
o-	NULL
=o	NULL
+	NULL
4	NULL
#	NULL
o-	NULL
-o	NULL
t	NULL
-	NULL
+	NULL
om	NULL
PNE	NULL
soos	NULL
#	NULL
oJe	NULL
aos	NULL
sow	NULL
#	NULL
|x	NULL
ms	NULL
a	NULL
sos	NULL
rea	NULL
_	NULL
_*~	NULL
8	NULL
[	NULL
~	NULL
es	NULL
ane	NULL
ane	NULL
d	NULL
|	NULL
|	NULL
IRF-2	NULL
Im	NULL
I	NULL
I	NULL
ACTIN	NULL
pﬁﬁ	NULL
‘	NULL
ﬁﬁﬁﬁﬁt	NULL
’	NULL
k3ﬂil=§éaﬁ¥	NULL
”	NULL
tw	NULL
L	NULL
|	NULL
|	NULL
|	NULL
|	NULL
]	NULL
hours	NULL
0.5	NULL
1	NULL
2	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Kinetics	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
gene	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Total	NULL
RNAs	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
of	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
inducers	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
or	NULL
2	NULL
h	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
with	NULL
the	NULL
IRF-l-radiolabeled	NULL
probe	NULL
.	NULL

After	NULL
dehybridization	NULL
,	NULL
the	NULL
same	NULL
membrane	NULL
transfer	NULL
was	NULL
successively	NULL
hybridized	NULL
with	NULL
IRF-2	NULL
and	NULL
actin	NULL
probes	NULL
.	NULL

Arrows	NULL
indicate	NULL
specific	NULL
mRNA	NULL
.	NULL

9	NULL
,	NULL
IFN-y	NULL
already	NULL
induced	NULL
IRF-1	NULL
mRNA	NULL
after	NULL
30	NULL
min	NULL
,	NULL
in	NULL
an	NULL
amount	NULL
which	NULL
increased	NULL
for	NULL
up	NULL
to	NULL
2	NULL
h	NULL
of	NULL
cell	NULL
stimulation	NULL
.	NULL

No	NULL
synergistic	NULL
effect	NULL
was	NULL
observed	NULL
after	NULL
combined	NULL
treatment	NULL
with	NULL
IFN-y	NULL
and	NULL
TNF-	NULL
@	NULL
.	NULL

Stimulation	NULL
by	NULL
IFN-a	NULL
«	NULL
also	NULL
triggered	NULL
IRF-1	NULL
gene	NULL
expression	NULL
,	NULL
but	NULL
with	NULL
different	NULL
kinetics	NULL
of	NULL
accumulation	NULL
since	NULL
IRF-1	NULL
mRNA	NULL
was	NULL
barely	NULL
detected	NULL
after	NULL
1	NULL
h	NULL
of	NULL
IFN-	NULL
@	NULL
stimulation	NULL
but	NULL
its	NULL
amount	NULL
increased	NULL
thereafter	NULL
.	NULL

Two	NULL
IRF-1	NULL
mRNAs	NULL
of	NULL
2.1	NULL
and	NULL
3	NULL
kilobases	NULL
were	NULL
revealed	NULL
,	NULL
with	NULL
a	NULL
similar	NULL
accumulation	NULL
kinetic	NULL
.	NULL

Neither	NULL
TNF-a	NULL
@	NULL
nor	NULL
LPS	NULL
induced	NULL
IRF-1	NULL
gene	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IRF-2	NULL
mRNA	NULL
was	NULL
constitutively	NULL
expressed	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
modification	NULL
of	NULL
the	NULL
IRF-2	NULL
mRNA	NULL
level	NULL
was	NULL
observed	NULL
whatever	NULL
the	NULL
period	NULL
of	NULL
incubation	NULL
and	NULL
the	NULL
inducers	NULL
used	NULL
.	NULL

The	NULL
reduction	NULL
in	NULL
the	NULL
level	NULL
of	NULL
this	NULL
protein	NULL
after	NULL
stimula-tions	NULL
with	NULL
various	NULL
inducers	NULL
,	NULL
without	NULL
concomitant	NULL
decrease	NULL
in	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
the	NULL
IRF-2	NULL
mRNA	NULL
level	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
make	NULL
sure	NULL
that	NULL
IRF-2	NULL
mRNA	NULL
was	NULL
functionally	NULL
active	NULL
.	NULL

Accordingly	NULL
,	NULL
total	NULL
RNAs	NULL
were	NULL
extracted	NULL
from	NULL
cells	NULL
left	NULL
untreated	NULL
from	NULL
2	NULL
h	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
,	NULL
using	NULL
reticulocyte	NULL
lysate	NULL
and	NULL
thionine	NULL
.	NULL

Identical	NULL
number	NULL
of	NULL
counts/min	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cpm	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
immuno-Western	NULL
blot	NULL
,	NULL
using	NULL
specific	NULL
IRF-2	NULL
antibodies	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
IRF-2	NULL
protein	NULL
were	NULL
detected	NULL
whatever	NULL
the	NULL
inducers	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
differential	NULL
regulation	NULL
of	NULL
IRF-2	NULL
protein	NULL
by	NULL
IFN-y	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
IFN-a	NULL
takes	NULL
place	NULL
at	NULL
post	NULL
translational	NULL
level	NULL
.	NULL

DISCUSSION	NULL
We	NULL
investigated	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
IFN-y/TNF-	NULL
@	NULL
-mediated	NULL
synergistic	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
gene	NULL
in	NULL
the	NULL
THP-1	NULL
monocytic	NULL
cell	NULL
line	NULL
by	NULL
functional	NULL
analysis	NULL
of	NULL
this	NULL
gene	NULL
's	NULL
promoter	NULL
.	NULL

The	NULL
results	NULL
provided	NULL
evidence	NULL
that	NULL
three	NULL
regions	NULL
inside	NULL
this	NULL
promoter	NULL
are	NULL
the	NULL
targets	NULL
of	NULL
the	NULL
IFN-y/TNF-a	NULL
action	NULL
:	NULL
(	NULL
i	NULL
)	NULL
a	NULL
region	NULL
between	NULL
-73	NULL
and	NULL
-36	NULL
,	NULL
which	NULL
constitutes	NULL
the	NULL
minimal	NULL
element	NULL
inducible	NULL
by	NULL
LPS	NULL
or	NULL
TNF-a	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
an	NULL
element	NULL
located	NULL
between	NULL
-181	NULL
and	NULL
-73	NULL
,	NULL
which	NULL
appears	NULL
to	NULL
regulate	NULL
negatively	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
and	NULL
TNF-a	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
a	NULL
distal	NULL
element	NULL
upstream	NULL
of	NULL
-224	NULL
,	NULL
which	NULL
is	NULL
the	NULL
only	NULL
one	NULL
inducible	NULL
by	NULL
IFN-y	NULL
alone	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
DNA	NULL
elements	NULL
corresponding	NULL
to	NULL
the	NULL
three	NULL
functional	NULL
regions	NULL
inducible	NULL
by	NULL
IFN-y	NULL
and/or	NULL
TNF-a	NULL
and	NULL
by	NULL
LPS	NULL
led	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

The	NULL
IL-6	NULL
promoter	NULL
DNA	NULL
fragment	NULL
between	NULL
-73	NULL
and	NULL
-36	NULL
was	NULL
found	NULL
to	NULL
contain	NULL
an	NULL
NFxB-like	NULL
element	NULL
near	NULL
a	NULL
putative	NULL
AP-1	NULL
binding	NULL
motif	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
,	NULL
TNF-a	NULL
or	NULL
LPS	NULL
induced	NULL
binding	NULL
to	NULL
this	NULL
DNA	NULL
motif	NULL
,	NULL
whereas	NULL
IFN-y	NULL
neither	NULL
induced	NULL
NFB	NULL
binding	NULL
activity	NULL
nor	NULL
amplified	NULL
the	NULL
effect	NULL
of	NULL
TNF-a	NULL
when	NULL
added	NULL
together	NULL
with	NULL
it	NULL
.	NULL

The	NULL
EMSA-DNA	NULL
competition	NULL
experiments	NULL
with	NULL
consensus	NULL
immunoglobulin-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
allowed	NULL
us	NULL
to	NULL
conclude	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
induced	NULL
by	NULL
TNF-a	NULL
and	NULL
LPS	NULL
is	NULL
due	NULL
to	NULL
NFB	NULL
binding	NULL
factors	NULL
.	NULL

EMSA	NULL
including	NULL
antibodies	NULL
and	NULL
immunoprecipitation	NULL
with	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
NFB	NULL
subunit	NULL
antibodies	NULL
revealed	NULL
only	NULL
the	NULL
nuclear	NULL
accumulation	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
after	NULL
stimulation	NULL
by	NULL
LPS	NULL
.	NULL

The	NULL
predominance	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
major	NULL
factor	NULL
induced	NULL
by	NULL
TNF-a	NULL
or	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
.	NULL

Various	NULL
dimer	NULL
combinations	NULL
of	NULL
induced	NULL
factors	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
stimulus-dependent	NULL
and	NULL
to	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
by	NULL
activating	NULL
distinct	NULL
sets	NULL
ot	NULL
target	NULL
genes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
homodimer	NULL
p65	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
selectively	NULL
activated	NULL
in	NULL
other	NULL
systems	NULL
by	NULL
TNF-	NULL
«	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NFxB	NULL
binding	NULL
activity	NULL
by	NULL
TNF-a	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
concomitant	NULL
IL-6	NULL
production	NULL
(	NULL
22	NULL
)	NULL
,	NULL
but	NULL
required	NULL
the	NULL
addition	NULL
of	NULL
IFN-y	NULL
,	NULL
unlike	NULL
activation	NULL
by	NULL
LPS	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
the	NULL
mechanism	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
endogenous	NULL
IL-6	NULL
gene	NULL
in	NULL
THP-1	NULL
cells	NULL
is	NULL
inducer-specific	NULL
.	NULL

Although	NULL
NFB	NULL
binding	NULL
factors	NULL
are	NULL
certainly	NULL
involved	NULL
in	NULL
IL-6	NULL
gene	NULL
induction	NULL
,	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
IL-6-CAT	NULL
construct	NULL
deletions	NULL
reported	NULL
here	NULL
shows	NULL
that	NULL
significantly	NULL
greater	NULL
stimulation	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
is	NULL
obtained	NULL
for	NULL
constructs	NULL
that	NULL
contain	NULL
the	NULL
5	NULL
'	NULL
distal	NULL
sequence	NULL
of	NULL
IL-6	NULL
promoter	NULL
(	NULL
pr-1200	NULL
)	NULL
.	NULL

Successive	NULL
deletions	NULL
of	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
fragment	NULL
(	NULL
-1200	NULL
to	NULL
-108	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
gradual	NULL
reduction	NULL
of	NULL
synergistic	NULL
CAT	NULL
activity	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
.	NULL

EMSA	NULL
using	NULL
the	NULL
oligonucleotide	NULL
E/-283	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
copy	NULL
of	NULL
IFN-enhancer-core	NULL
sequence	NULL
,	NULL
showed	NULL
that	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
TNF-a	NULL
or	NULL
LPS	NULL
,	NULL
induced	NULL
specific	NULL
binding	NULL
activity	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
C3	NULL
oligonucleotide	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
IRF-l-related	NULL
factor	NULL
was	NULL
a	NULL
component	NULL
of	NULL
the	NULL
C1-	NULL
and	NULL
C2-specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

EMSA	NULL
experiments	NULL
using	NULL
antibodies	NULL
against	NULL
IRF-1	NULL
or	NULL
IRF	NULL
-2	NULL
allowed	NULL
us	NULL
to	NULL
conclude	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
constitutive	NULL
C1	NULL
complex	NULL
involved	NULL
IRF-2	NULL
binding	NULL
and	NULL
that	NULL
IRF-1	NULL
was	NULL
involved	NULL
,	NULL
both	NULL
in	NULL
the	NULL
binding	NULL
activity	NULL
27929	NULL
of	NULL
the	NULL
inducible	NULL
C2	NULL
complex	NULL
and	NULL
in	NULL
the	NULL
increased	NULL
abundance	NULL
of	NULL
the	NULL
C1	NULL
complex	NULL
due	NULL
to	NULL
stimulation	NULL
by	NULL
IFN-y	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
transfection	NULL
of	NULL
construct	NULL
del	NULL
(	NULL
-224	NULL
)	NULL
/Emt31	NULL
into	NULL
THP-1	NULL
cells	NULL
confirmed	NULL
that	NULL
the	NULL
IFN-enhancer-core	NULL
sequence	NULL
AAAGG	NULL
,	NULL
which	NULL
is	NULL
located	NULL
between	NULL
-253	NULL
and	NULL
-248	NULL
(	NULL
13	NULL
)	NULL
,	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
response	NULL
to	NULL
IFN-y	NULL
alone	NULL
.	NULL

The	NULL
IRF-1	NULL
binding	NULL
site	NULL
identified	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
central	NULL
motif	NULL
of	NULL
the	NULL
IFN-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
IFN-o-stimulated	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
2',5'-oligo	NULL
(	NULL
A	NULL
)	NULL
-synthetase	NULL
gene	NULL
(	NULL
43	NULL
)	NULL
.	NULL

In	NULL
EMSA	NULL
using	NULL
the	NULL
E/-283	NULL
probe	NULL
,	NULL
the	NULL
IRF-related	NULL
complexes	NULL
C1	NULL
and	NULL
C2	NULL
were	NULL
impaired	NULL
by	NULL
the	NULL
ISRE	NULL
oligonucleotide	NULL
.	NULL

However	NULL
,	NULL
after	NULL
IFN-a	NULL
treatment	NULL
,	NULL
no	NULL
C1	NULL
or	NULL
C2	NULL
binding	NULL
activity	NULL
was	NULL
observed	NULL
.	NULL

When	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
ISRE	NULL
oligonucleotide	NULL
for	NULL
purposes	NULL
of	NULL
comparison	NULL
,	NULL
it	NULL
only	NULL
revealed	NULL
ISGF3-related	NULL
complexes	NULL
after	NULL
IFN-a	NULL
treatment	NULL
,	NULL
as	NULL
expected	NULL
(	NULL
24-27	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
IRF-1	NULL
protein-DNA	NULL
binding	NULL
by	NULL
IFN-y	NULL
correlated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
and	NULL
with	NULL
the	NULL
concomitant	NULL
IRF-1	NULL
protein	NULL
synthesis	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
IRF-2	NULL
mRNA	NULL
constitutive	NULL
expression	NULL
was	NULL
not	NULL
modified	NULL
whatever	NULL
the	NULL
inducers	NULL
,	NULL
whereas	NULL
the	NULL
level	NULL
of	NULL
constitutive	NULL
IRF-2	NULL
protein	NULL
decreased	NULL
transiently	NULL
after	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
treatment	NULL
.	NULL

LPS	NULL
or	NULL
IFN-	NULL
«	NULL
treatment	NULL
led	NULL
to	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
constitutive	NULL
IRF-2	NULL
protein	NULL
.	NULL

The	NULL
different	NULL
effects	NULL
exerted	NULL
on	NULL
IRF-2	NULL
protein	NULL
down-regulation	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
and	NULL
by	NULL
LPS	NULL
on	NULL
the	NULL
other	NULL
might	NULL
partly	NULL
account	NULL
for	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
magnitude	NULL
of	NULL
IL-6	NULL
induction	NULL
by	NULL
each	NULL
of	NULL
these	NULL
inducers	NULL
in	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

LPS	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
induce	NULL
or	NULL
activate	NULL
proteins	NULL
that	NULL
recognize	NULL
the	NULL
3'-end	NULL
instability	NULL
sequence	NULL
of	NULL
an	NULL
mRNA	NULL
that	NULL
prevents	NULL
the	NULL
latter	NULL
's	NULL
translation	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
mechanism	NULL
might	NULL
account	NULL
for	NULL
the	NULL
down-regulation	NULL
of	NULL
IRF-2	NULL
protein	NULL
in	NULL
vivo	NULL
,	NULL
since	NULL
here	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
show	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
that	NULL
this	NULL
inducer	NULL
modulates	NULL
either	NULL
the	NULL
expression	NULL
of	NULL
mRNA	NULL
IRF-2	NULL
or	NULL
its	NULL
translation	NULL
in	NULL
vitro	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
constitutive	NULL
IRF-2	NULL
protein	NULL
might	NULL
be	NULL
rapidly	NULL
degraded	NULL
after	NULL
its	NULL
activation	NULL
by	NULL
IFN-y	NULL
or	NULL
LPS	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
other	NULL
systems	NULL
(	NULL
53	NULL
)	NULL
,	NULL
thus	NULL
allowing	NULL
the	NULL
binding	NULL
of	NULL
another	NULL
activator	NULL
which	NULL
in	NULL
the	NULL
case	NULL
of	NULL
IFN-y	NULL
would	NULL
be	NULL
IRF-1	NULL
.	NULL

As	NULL
LPS	NULL
did	NULL
not	NULL
,	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
,	NULL
induce	NULL
IRF-1	NULL
,	NULL
we	NULL
might	NULL
be	NULL
justified	NULL
in	NULL
assuming	NULL
that	NULL
one	NULL
or	NULL
several	NULL
other	NULL
factors	NULL
activated	NULL
by	NULL
LPS	NULL
could	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
factor	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
our	NULL
functional	NULL
CAT	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
IRF-1	NULL
may	NULL
be	NULL
a	NULL
critical	NULL
downstream	NULL
signaling	NULL
factor	NULL
involved	NULL
in	NULL
IFN-y	NULL
signal	NULL
transduction	NULL
in	NULL
mono-cytes/macrophages	NULL
,	NULL
particularly	NULL
for	NULL
genes	NULL
whose	NULL
maximal	NULL
expression	NULL
is	NULL
triggered	NULL
by	NULL
combined	NULL
treatment	NULL
with	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
(	NULL
22	NULL
,	NULL
54-56	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
TNF-a	NULL
induced	NULL
NFB	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
correlated	NULL
with	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
del	NULL
(	NULL
-73	NULL
)	NULL
-CAT	NULL
construct	NULL
but	NULL
failed	NULL
to	NULL
induce	NULL
reporter	NULL
constructs	NULL
containing	NULL
additional	NULL
upstream	NULL
sequences	NULL
,	NULL
suggests	NULL
that	NULL
a	NULL
silencer	NULL
of	NULL
NFxB	NULL
activity	NULL
must	NULL
be	NULL
present	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
deletion	NULL
constructs	NULL
indicated	NULL
that	NULL
this	NULL
negative	NULL
element	NULL
might	NULL
be	NULL
located	NULL
between	NULL
-181	NULL
and	NULL
-73	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
,	NULL
among	NULL
others	NULL
,	NULL
a	NULL
retinoblastoma	NULL
control	NULL
element	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
pRb-mediated	NULL
repression	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
,	NULL
as	NULL
reported	NULL
by	NULL
Santhanam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
of	NULL
a	NULL
region	NULL
analogous	NULL
to	NULL
the	NULL
RCE	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
between	NULL
positions	NULL
-126/	NULL
-101	NULL
,	NULL
exhibiting	NULL
similar	NULL
patterns	NULL
of	NULL
c-fos	NULL
and	NULL
IL-6	NULL
promoters	NULL
regulation	NULL
,	NULL
suggests	NULL
that	NULL
RCE	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
IL-6	NULL
gene	NULL
repression	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Evidence	NULL
that	NULL
RCE	NULL
has	NULL
a	NULL
repressor	NULL
role	NULL
was	NULL
obtained	NULL
,	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
,	NULL
by	NULL
deletion	NULL
experiments	NULL
and	NULL
cotransfections	NULL
of	NULL
IL-6	NULL
promoter	NULL
with	NULL
pRB	NULL
express	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
27930	NULL
ing	NULL
vector	NULL
(	NULL
17	NULL
)	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
suggest	NULL
that	NULL
alteration	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
putative	NULL
suppressor	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
and	NULL
RCE	NULL
allowed	NULL
us	NULL
to	NULL
obtain	NULL
a	NULL
synergistic	NULL
effect	NULL
of	NULL
IFN-y	NULL
with	NULL
TNF-a	NULL
«	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Synergistic	NULL
CAT	NULL
induction	NULL
was	NULL
observed	NULL
for	NULL
del	NULL
(	NULL
-181	NULL
)	NULL
but	NULL
not	NULL
for	NULL
del	NULL
(	NULL
-108	NULL
)	NULL
.	NULL

The	NULL
del	NULL
(	NULL
-181	NULL
)	NULL
-CAT	NULL
construct	NULL
contains	NULL
the	NULL
intact	NULL
IL-6-RCE	NULL
motif	NULL
,	NULL
whereas	NULL
a	NULL
truncated	NULL
RCE	NULL
motif	NULL
is	NULL
present	NULL
in	NULL
the	NULL
del	NULL
(	NULL
-108	NULL
)	NULL
-CAT	NULL
construct	NULL
.	NULL

EMSA	NULL
experiments	NULL
performed	NULL
with	NULL
oligonucleotide	NULL
B/-126	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
IL-6-RCE	NULL
motif	NULL
,	NULL
revealed	NULL
one	NULL
major	NULL
constitutive	NULL
specific	NULL
RCE-protein	NULL
complex	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
THP-1	NULL
cells	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
consensus	NULL
Sp1	NULL
oligonucleotide	NULL
and	NULL
was	NULL
supershifted	NULL
by	NULL
Sp1	NULL
antibodies	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
recombinant	NULL
Sp1	NULL
protein	NULL
increased	NULL
this	NULL
site	NULL
occupancy	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
showed	NULL
by	NULL
shift-Western	NULL
blot	NULL
analysis	NULL
that	NULL
Sp1	NULL
protein	NULL
is	NULL
part	NULL
of	NULL
the	NULL
IL-6-RCE-protein	NULL
complex	NULL
,	NULL
whereas	NULL
Rb	NULL
protein	NULL
,	NULL
undetectable	NULL
in	NULL
this	NULL
complex	NULL
,	NULL
was	NULL
not	NULL
.	NULL

Our	NULL
observations	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
hypothesis	NULL
proposed	NULL
by	NULL
Udvadia	NULL
et	NULL
al	NULL
.	NULL

that	NULL
Rb	NULL
regulates	NULL
transcription	NULL
partly	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
functionally	NULL
with	NULL
RB	NULL
control	NULL
proteins	NULL
,	NULL
including	NULL
Sp1	NULL
(	NULL
45	NULL
,	NULL
57-60	NULL
)	NULL
.	NULL

EMSA	NULL
performed	NULL
with	NULL
the	NULL
Sp1	NULL
consensus	NULL
probe	NULL
showed	NULL
that	NULL
stimulation	NULL
of	NULL
THP-1	NULL
cells	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-	NULL
«	NULL
enhanced	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
.	NULL

This	NULL
result	NULL
correlates	NULL
with	NULL
a	NULL
marked	NULL
increase	NULL
by	NULL
IFN-y	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
serine-phosphorylated	NULL
Sp1	NULL
protein	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Spl	NULL
is	NULL
selectively	NULL
phosphorylated	NULL
upon	NULL
binding	NULL
to	NULL
its	NULL
cognate	NULL
recognition	NULL
elements	NULL
on	NULL
DNA	NULL
,	NULL
suggesting	NULL
that	NULL
phosphorylation	NULL
represents	NULL
an	NULL
early	NULL
event	NULL
in	NULL
the	NULL
processes	NULL
leading	NULL
to	NULL
transcriptional	NULL
activation	NULL
by	NULL
Spl	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Sp1	NULL
is	NULL
catalyzed	NULL
by	NULL
a	NULL
double-stranded	NULL
DNA-dependent	NULL
kinase	NULL
and	NULL
requires	NULL
binding	NULL
to	NULL
DNA	NULL
containing	NULL
the	NULL
GC	NULL
box	NULL
(	NULL
34	NULL
,	NULL
61	NULL
)	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
postulate	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
was	NULL
partly	NULL
mediated	NULL
by	NULL
increased	NULL
binding	NULL
of	NULL
Sp1	NULL
to	NULL
its	NULL
target	NULL
sequence	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
,	NULL
with	NULL
concomitant	NULL
Sp1	NULL
factor	NULL
activation	NULL
by	NULL
specific	NULL
phosphorylation	NULL
.	NULL

This	NULL
alteration	NULL
might	NULL
impair	NULL
the	NULL
negative	NULL
effect	NULL
mediated	NULL
by	NULL
the	NULL
IL-6-RCE	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
NFB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
synergize	NULL
with	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
Sp1	NULL
(	NULL
62	NULL
,	NULL
63	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
Sp1	NULL
specifically	NULL
interacts	NULL
with	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
Rel	NULL
A	NULL
(	NULL
p65	NULL
)	NULL
;	NULL
similarly	NULL
,	NULL
Rel	NULL
A	NULL
(	NULL
p65	NULL
)	NULL
bound	NULL
directly	NULL
to	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
of	NULL
Spl	NULL
factor	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
specific	NULL
,	NULL
because	NULL
Rel	NULL
A	NULL
did	NULL
not	NULL
associate	NULL
with	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
be	NULL
zinc	NULL
finger	NULL
proteins	NULL
(	NULL
36-38	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
p65	NULL
homodimer	NULL
induced	NULL
by	NULL
TNF-a	NULL
in	NULL
THP-1	NULL
cells	NULL
is	NULL
not	NULL
,	NULL
by	NULL
itself	NULL
,	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-6	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
can	NULL
postulate	NULL
that	NULL
functional	NULL
interaction	NULL
between	NULL
p65	NULL
NFxB	NULL
and	NULL
the	NULL
activated-Sp1	NULL
bound	NULL
to	NULL
the	NULL
adjacent	NULL
target	NULL
Sp1	NULL
site	NULL
contributed	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
.	NULL

Our	NULL
observations	NULL
allowed	NULL
us	NULL
to	NULL
conclude	NULL
that	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
by	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
@	NULL
,	NULL
or	NULL
by	NULL
LPS	NULL
treatment	NULL
is	NULL
mediated	NULL
through	NULL
different	NULL
signaling	NULL
pathways	NULL
.	NULL

LPS	NULL
signaling	NULL
was	NULL
shown	NULL
to	NULL
involve	NULL
interaction	NULL
with	NULL
CD14	NULL
(	NULL
64	NULL
,	NULL
65	NULL
)	NULL
,	NULL
which	NULL
triggered	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
Ras-Rafl-dependent	NULL
cascade	NULL
,	NULL
leading	NULL
to	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
translocation	NULL
allowing	NULL
accumulation	NULL
of	NULL
the	NULL
p50/p65	NULL
NFB	NULL
heterodimer	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
23	NULL
,	NULL
66-68	NULL
)	NULL
.	NULL

Since	NULL
this	NULL
p50/p65	NULL
complex	NULL
was	NULL
also	NULL
identified	NULL
in	NULL
our	NULL
cell	NULL
system	NULL
,	NULL
a	NULL
similar	NULL
pathway	NULL
might	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
IL-6	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
LPS	NULL
treatment	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
IFN-y	NULL
+	NULL
TNF-a	NULL
on	NULL
IL-6	NULL
gene	NULL
induction	NULL
in	NULL
THP-1	NULL
cells	NULL
might	NULL
involve	NULL
three	NULL
simultaneous	NULL
processes	NULL
.	NULL

The	NULL
first	NULL
process	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
NFB	NULL
by	NULL
TNF-a	NULL
by	NULL
a	NULL
different	NULL
pathway	NULL
from	NULL
that	NULL
of	NULL
activation	NULL
by	NULL
LPS	NULL
,	NULL
Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
p65	NULL
homodimer	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
recent	NULL
report	NULL
showing	NULL
that	NULL
,	NULL
in	NULL
murine	NULL
macro-phages	NULL
,	NULL
TNF-a	NULL
activates	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
in	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase-dependent	NULL
but	NULL
c-Raf-l-independent	NULL
fashion	NULL
(	NULL
69	NULL
)	NULL
.	NULL

The	NULL
second	NULL
process	NULL
is	NULL
the	NULL
induction	NULL
of	NULL
IRF-1	NULL
by	NULL
IFN-y	NULL
through	NULL
a	NULL
signaling	NULL
pathway	NULL
involving	NULL
the	NULL
activation	NULL
of	NULL
Jak1/Jak2	NULL
and	NULL
Stat	NULL
1	NULL
(	NULL
70-75	NULL
)	NULL
.	NULL

The	NULL
third	NULL
process	NULL
is	NULL
a	NULL
concomitant	NULL
change	NULL
by	NULL
IFN-y	NULL
,	NULL
in	NULL
the	NULL
state	NULL
of	NULL
phosphorylation	NULL
and	NULL
abundance	NULL
of	NULL
the	NULL
constitutive	NULL
Sp1	NULL
nuclear	NULL
factor	NULL
interacting	NULL
with	NULL
IL-6-RCE	NULL
.	NULL

The	NULL
phosphoserine	NULL
kinase	NULL
implicated	NULL
in	NULL
the	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
phosphorylation	NULL
of	NULL
Sp1	NULL
,	NULL
presumably	NULL
activated	NULL
by	NULL
IFN-y	NULL
,	NULL
remains	NULL
to	NULL
be	NULL
investigated	NULL
.	NULL

Transcriptional	NULL
induction	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
might	NULL
result	NULL
from	NULL
a	NULL
coordinated	NULL
effect	NULL
exerted	NULL
by	NULL
factor	NULL
Sp1	NULL
together	NULL
with	NULL
IRF-1	NULL
and	NULL
p65	NULL
homodimer-NFxB	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
regulation	NULL
by	NULL
IFN-y	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
in	NULL
human	NULL
monocytes	NULL
involved	NULL
IRF-1	NULL
may	NULL
be	NULL
more	NULL
generally	NULL
related	NULL
to	NULL
the	NULL
tumor	NULL
suppressor/differentiation	NULL
properties	NULL
of	NULL
IFN-y	NULL
(	NULL
82	NULL
,	NULL
76	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
a	NULL
chromosomal	NULL
segment	NULL
that	NULL
contains	NULL
the	NULL
IRF-1	NULL
gene	NULL
,	NULL
mapped	NULL
in	NULL
chromosome	NULL
5q31.1	NULL
,	NULL
is	NULL
very	NULL
often	NULL
observed	NULL
in	NULL
human	NULL
leukemia	NULL
(	NULL
77	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
an	NULL
alteration	NULL
in	NULL
the	NULL
balance	NULL
of	NULL
IRF-1/IRF-2	NULL
may	NULL
impair	NULL
optimal	NULL
physiological	NULL
induction	NULL
of	NULL
IL-6	NULL
by	NULL
IFN-y/TNF-a	NULL
@	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
com-partment	NULL
,	NULL
leading	NULL
to	NULL
abnormal	NULL
cell	NULL
maturation	NULL
and	NULL
proliferation	NULL
in	NULL
certain	NULL
hematological	NULL
disorders	NULL
and	NULL
to	NULL
neoplasia	NULL
.	NULL

Alterations	NULL
in	NULL
IL-6	NULL
production	NULL
such	NULL
as	NULL
overexpression	NULL
in	NULL
multiple	NULL
myeloma	NULL
and	NULL
other	NULL
type	NULL
of	NULL
cancers	NULL
(	NULL
2-9	NULL
,	NULL
78	NULL
,	NULL
79	NULL
)	NULL
or	NULL
inhibition	NULL
in	NULL
Fanconi	NULL
's	NULL
anemia	NULL
(	NULL
10	NULL
,	NULL
80	NULL
)	NULL
may	NULL
be	NULL
suspected	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
pathological	NULL
cell	NULL
growth	NULL
and	NULL
to	NULL
affect	NULL
hematopoi-etic	NULL
cell	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
triggering	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
by	NULL
IFN-y	NULL
in	NULL
monocytic	NULL
cells	NULL
required	NULL
the	NULL
induction	NULL
of	NULL
IRF-1	NULL
and	NULL
involved	NULL
phosphorylated	NULL
Sp1	NULL
protein	NULL
may	NULL
be	NULL
of	NULL
physiological	NULL
relevance	NULL
,	NULL
and	NULL
one	NULL
of	NULL
the	NULL
important	NULL
homeostatic	NULL
properties	NULL
of	NULL
IFN-y	NULL
within	NULL
the	NULL
cytokine	NULL
network	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
T.	NULL
Taniguchi	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
cDNAs	NULL
,	NULL
Dr.	NULL
G.	NULL
R.	NULL
Adolf	NULL
(	NULL
Boeh-ringer-Ingelheim	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
human	NULL
TNF-a	NULL
,	NULL
and	NULL
Dr.	NULL
Lando	NULL
(	NULL
Roussel-Uclaf	NULL
,	NULL
Romainville	NULL
,	NULL
France	NULL
)	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
human	NULL
IFN-y	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
A.	NULL
Birot	NULL
for	NULL
expert	NULL
secretarial	NULL
assistance	NULL
and	NULL
to	NULL
C.	NULL
Sylvestri	NULL
for	NULL
valuable	NULL
technical	NULL
assistance	NULL
for	NULL
plasmid-DNA	NULL
puri-fications	NULL
and	NULL
cell	NULL
cultures	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Sehgal	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
May	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Vilceck	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Science	NULL
285	NULL
,	NULL
73-74	NULL
2	NULL
.	NULL

Revel	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Experientia	NULL
(	NULL
Basel	NULL
)	NULL
45	NULL
,	NULL
549-557	NULL
3	NULL
.	NULL

Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

7	NULL
,	NULL
117-130	NULL
4	NULL
.	NULL

Hirano	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Chem	NULL
.	NULL

Immunol	NULL
.	NULL

51	NULL
,	NULL
153-180	NULL
5	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Morio	NULL
,	NULL
T.	NULL
,	NULL
Tohda	NULL
,	NULL
S.	NULL
,	NULL
Nagata	NULL
,	NULL
K.	NULL
,	NULL
Yamashita	NULL
,	NULL
Y.	NULL
,	NULL
Imai	NULL
,	NULL
Y.	NULL
,	NULL
Aoki	NULL
,	NULL
N.	NULL
,	NULL
Hirashima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nara	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

81	NULL
,	NULL
979-986	NULL
6	NULL
.	NULL

Emilie	NULL
,	NULL
D.	NULL
,	NULL
Coumbaras	NULL
,	NULL
J.	NULL
,	NULL
Raphael	NULL
,	NULL
M.	NULL
,	NULL
Devergne	NULL
,	NULL
D.	NULL
,	NULL
Delecluse	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Gisselbrecht	NULL
,	NULL
C.	NULL
,	NULL
Michiels	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
VanDamme	NULL
,	NULL
J.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
Crevon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Galanaud	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
498-504	NULL
7	NULL
.	NULL

Porgador	NULL
,	NULL
A.	NULL
,	NULL
Tzehoval	NULL
,	NULL
E.	NULL
,	NULL
Katz	NULL
,	NULL
A.	NULL
,	NULL
Vadai	NULL
,	NULL
E.	NULL
,	NULL
Revel	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Eisenbach	NULL
,	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

52	NULL
,	NULL
3679-3686	NULL
8	NULL
.	NULL

Inoue	NULL
,	NULL
K.	NULL
,	NULL
Sugiyama	NULL
,	NULL
H.	NULL
,	NULL
Ogawa	NULL
,	NULL
H.	NULL
,	NULL
Yamagami	NULL
,	NULL
T.	NULL
,	NULL
Azuma	NULL
,	NULL
T.	NULL
,	NULL
Oka	NULL
,	NULL
Y.	NULL
,	NULL
Miwa	NULL
,	NULL
H.	NULL
,	NULL
Kita	NULL
,	NULL
K.	NULL
,	NULL
Hiraoka	NULL
,	NULL
A.	NULL
,	NULL
Masaoko	NULL
,	NULL
T.	NULL
,	NULL
Nasu	NULL
,	NULL
K.	NULL
,	NULL
Kyo	NULL
,	NULL
T.	NULL
,	NULL
Dohy	NULL
,	NULL
H.	NULL
,	NULL
Hara	NULL
,	NULL
J.	NULL
,	NULL
Kanamura	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
2672-2680	NULL
9	NULL
.	NULL

Klein	NULL
,	NULL
B.	NULL
,	NULL
Zhang	NULL
,	NULL
X.	NULL
G.	NULL
,	NULL
Lu	NULL
,	NULL
Z.	NULL
Y.	NULL
,	NULL
and	NULL
Bataille	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
863-872	NULL
10	NULL
.	NULL

Rosselli	NULL
,	NULL
F.	NULL
,	NULL
Sancéau	NULL
,	NULL
J.	NULL
,	NULL
Wietzerbin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Moustacchi	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

89	NULL
,	NULL
42-48	NULL
11	NULL
.	NULL

Bagnara	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Bonsi	NULL
,	NULL
L.	NULL
,	NULL
Strippoli	NULL
,	NULL
P.	NULL
,	NULL
Ramenghi	NULL
,	NULL
U.	NULL
,	NULL
Timeus	NULL
,	NULL
F.	NULL
,	NULL
Bonifazi	NULL
,	NULL
F.	NULL
,	NULL
Bonafé	NULL
,	NULL
M.	NULL
,	NULL
Tonelli	NULL
,	NULL
R.	NULL
,	NULL
Bubola	NULL
,	NULL
G.	NULL
,	NULL
Brizzi	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Vitale	NULL
,	NULL
L.	NULL
,	NULL
Paolucci	NULL
,	NULL
G.	NULL
,	NULL
Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Gabutti	NULL
,	NULL
V.	NULL
(	NULL
1993	NULL
)	NULL
Stem	NULL
Cell	NULL
11	NULL
,	NULL
137-143	NULL
12	NULL
.	NULL

Ray	NULL
,	NULL
A.	NULL
,	NULL
Tatter	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
May	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
6701-6705	NULL
13	NULL
.	NULL

Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Kamiya	NULL
,	NULL
T.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

141	NULL
,	NULL
3875-3881	NULL
14	NULL
.	NULL

Dendorfer	NULL
,	NULL
U.	NULL
,	NULL
Oettgen	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Libermann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4448-4454	NULL
15	NULL
.	NULL

Mori	NULL
,	NULL
N.	NULL
,	NULL
Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
Shimizu	NULL
,	NULL
H.	NULL
,	NULL
Murakami	NULL
,	NULL
S.	NULL
,	NULL
Oda	NULL
,	NULL
S.	NULL
,	NULL
Yamamoto	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Eto	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
2904-2911	NULL
16	NULL
.	NULL

Kiehntopf	NULL
,	NULL
M.	NULL
,	NULL
Herman	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Brach	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
793-798	NULL
17	NULL
.	NULL

Santhanam	NULL
,	NULL
U.	NULL
,	NULL
Ray	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
7605-7609	NULL
18	NULL
.	NULL

Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
,	NULL
Watanabe	NULL
,	NULL
Y.	NULL
,	NULL
Muratani	NULL
,	NULL
K.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Nakai	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2939-2945	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Role	NULL
of	NULL
IRF-1	NULL
,	NULL
NFkB	NULL
,	NULL
and	NULL
Sp1	NULL
in	NULL
Human	NULL
IL-6	NULL
Gene	NULL
Regulation	NULL
Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2327-2334	NULL
Shimizu	NULL
,	NULL
H.	NULL
,	NULL
Mitomo	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
T.	NULL
,	NULL
Okamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
K.	NULL
I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
561-568	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

285	NULL
,	NULL
199-212	NULL
Sancéau	NULL
,	NULL
J.	NULL
,	NULL
Wijdenes	NULL
,	NULL
J.	NULL
,	NULL
Revel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Wietzerbin	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2630-2637	NULL
Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
529-532	NULL
Decker	NULL
,	NULL
T.	NULL
,	NULL
Lew	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Mirkovitch	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
927-932	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
813-815	NULL
Fu	NULL
,	NULL
X.	NULL
Y.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Improta	NULL
,	NULL
T.	NULL
,	NULL
Aebersold	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7840-7843	NULL
Veals	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Santa-Maria	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
196-206	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Fugita	NULL
,	NULL
T.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Furia	NULL
,	NULL
A.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
729-739	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Willison	NULL
,	NULL
K.	NULL
,	NULL
Sakakibara	NULL
,	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
303-312	NULL
Watanabe	NULL
,	NULL
N.	NULL
,	NULL
Sakakibara	NULL
,	NULL
J.	NULL
,	NULL
Hovanessian	NULL
,	NULL
A.	NULL
,	NULL
Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Fujita	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
4421-4428	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Kitagawa	NULL
,	NULL
M.	NULL
,	NULL
Tanaka	NULL
,	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
K.	NULL
,	NULL
Ishihara	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
971-974	NULL
Lengyel	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
5898-5895	NULL
Tanaka	NULL
,	NULL
N.	NULL
T.	NULL
,	NULL
Kawakami	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
4531-4538	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

285	NULL
,	NULL
194-198	NULL
Parrington	NULL
,	NULL
J.	NULL
,	NULL
Rogers	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Gewert	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
Veals	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

214	NULL
,	NULL
617-626	NULL
Pascal	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1646-1656	NULL
Jakson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
MacDonald	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Lees-Miller	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
155-165	NULL
Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Agranoff	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Pascal	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6570-6583	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
pp	NULL
.	NULL

7.19-7.22	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Labora-tory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Demezuk	NULL
,	NULL
S.	NULL
,	NULL
Harbers	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Vennstrim	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2574-2578	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Kuang	NULL
,	NULL
A.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8825-8829	NULL
Benech	NULL
,	NULL
P.	NULL
,	NULL
Vigneron	NULL
,	NULL
M.	NULL
,	NULL
Peretz	NULL
,	NULL
D.	NULL
,	NULL
Revel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chebath	NULL
.	NULL

,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
4498-4504	NULL
Fugita	NULL
,	NULL
T.	NULL
,	NULL
Sakakibara	NULL
,	NULL
J.	NULL
,	NULL
Sudo	NULL
,	NULL
Y.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
3397-3405	NULL
Udvadia	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Rogers	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
and	NULL
Horowitz	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Diff	NULL
.	NULL

8	NULL
,	NULL
597-608	NULL
Robbins	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Horowitz	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Mulligan	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
346	NULL
,	NULL
668-671	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Webb	NULL
,	NULL
D.	NULL
S.	NULL
A.	NULL
,	NULL
Sweitzer	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Petricoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1730-1733	NULL
Diehl	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Tong	NULL
,	NULL
W.	NULL
,	NULL
Sun	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hannink	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
2703-2707	NULL
Ledebur	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
and	NULL
Parks	NULL
,	NULL
T.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
933-948	NULL
Kruys	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Huez	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Biochemistry	NULL
76	NULL
,	NULL
862-866	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Bibbs	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
808-811	NULL
Lee	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Laydon	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
McDonnell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Gallagher	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
Kumar	NULL
,	NULL
S.	NULL
,	NULL
Green	NULL
,	NULL
D.	NULL
,	NULL
McNulty	NULL
,	NULL
D.	NULL
,	NULL
Blumenthal	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Heys	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Landvatter	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
53	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

TL	NULL
72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

279831	NULL
Strickler	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
McLaughlin	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Siemens	NULL
,	NULL
I.	NULL
R.	NULL
,	NULL
Fisher	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Livi	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
White	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Adams	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
872	NULL
,	NULL
739-746	NULL
.	NULL

Lin	NULL
,	NULL
R.	NULL
,	NULL
Mustafa	NULL
,	NULL
A.	NULL
,	NULL
Nguyen	NULL
,	NULL
H.	NULL
,	NULL
Gewert	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
17542-17549	NULL
Drapier	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Wietzerbin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hibbs	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

18	NULL
,	NULL
1587-1592	NULL
Wietzerbin	NULL
,	NULL
J.	NULL
,	NULL
Gaudelet	NULL
,	NULL
C.	NULL
,	NULL
Catinot	NULL
,	NULL
L.	NULL
,	NULL
Chebath	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Falcoff	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

48	NULL
,	NULL
149-155	NULL
Wanleng	NULL
,	NULL
D.	NULL
,	NULL
Thiel	NULL
,	NULL
B.	NULL
,	NULL
Tannenbaum	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Hamilton	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Stuebhr	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
322-829	NULL
Fisher	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Haese	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nowock	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
23915-23923	NULL
Udvadia	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Rogers	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Higgins	NULL
,	NULL
P.	NULL
D.	NULL
R.	NULL
,	NULL
Murata	NULL
,	NULL
Y.	NULL
,	NULL
Martin	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Humphrey	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Horowitz	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
3265-3269	NULL
Chen	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Nishinaka	NULL
,	NULL
T.	NULL
,	NULL
Kwan	NULL
,	NULL
K.	NULL
,	NULL
Kitabayashi	NULL
,	NULL
I.	NULL
,	NULL
Yakoyama	NULL
,	NULL
K.	NULL
,	NULL
Fu	NULL
,	NULL
Y.-H.	NULL
F.	NULL
,	NULL
Griinwald	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Chiu	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4380-4389	NULL
Jensen	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Rich	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
Terpstra	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Farmer	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Foster	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
6555-6563	NULL
Murata	NULL
,	NULL
Y.	NULL
,	NULL
Kim	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
Rogers	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Udvadia	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Horwitz	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
20674-20681	NULL
Ueda	NULL
,	NULL
A.	NULL
,	NULL
Okuda	NULL
,	NULL
K.	NULL
,	NULL
Ohno	NULL
,	NULL
S.	NULL
,	NULL
Shirai	NULL
,	NULL
A.	NULL
,	NULL
Igarashi	NULL
,	NULL
T.	NULL
,	NULL
Matsunaga	NULL
,	NULL
K.	NULL
,	NULL
Fukushima	NULL
,	NULL
J.	NULL
,	NULL
Kawamoto	NULL
,	NULL
S.	NULL
,	NULL
Ishigatsubo	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Okubo	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
2052-2063	NULL
Moll	NULL
,	NULL
T.	NULL
,	NULL
Czyz	NULL
,	NULL
M.	NULL
,	NULL
Holzmiiller	NULL
,	NULL
H.	NULL
,	NULL
Hofer-Warbinek	NULL
,	NULL
R.	NULL
,	NULL
Wagner	NULL
,	NULL
E.	NULL
,	NULL
Winkler	NULL
,	NULL
H.	NULL
,	NULL
Bach	NULL
,	NULL
F.	NULL
H.	NULL
,	NULL
and	NULL
Hofer	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
3849-3857	NULL
Gegner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
5320-5325	NULL
McGinley	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Narhi	NULL
,	NULL
L.	NULL
O.	NULL
,	NULL
Kelley	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Davy	NULL
,	NULL
E.	NULL
,	NULL
Robinson	NULL
,	NULL
J.	NULL
,	NULL
Rohde	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
and	NULL
Lichenstein	NULL
,	NULL
H.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
5213-5218	NULL
Weinsteir	NULL
,	NULL
8	NULL
.	NULL

L.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lemke	NULL
,	NULL
K.	NULL
,	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
14955-14962	NULL
Blumer	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
236-240	NULL
Reimann	NULL
,	NULL
T.	NULL
,	NULL
Biischer	NULL
,	NULL
D.	NULL
,	NULL
Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Krautwald	NULL
,	NULL
S.	NULL
,	NULL
Lohmann-Matthes	NULL
,	NULL
M.-L.	NULL
,	NULL
and	NULL
Baccarini	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
5740-5749	NULL
Winston	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Lange-Carter	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Gardner	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
and	NULL
Rihes	NULL
,	NULL
D.	NULL
W.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Nai	NULL
#	NULL
l	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
1614-1618	NULL
Shual	NULL
,	NULL
K.	NULL
,	NULL
Zlemiecki	NULL
,	NULL
A.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Sadowski	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
866	NULL
,	NULL
580-583	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
366	NULL
,	NULL
583-585	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
264	NULL
,	NULL
1415-1421	NULL
Igarashi	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
Garotta	NULL
,	NULL
G.	NULL
,	NULL
Ozmen	NULL
,	NULL
L.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Finbloom	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
14333-14336	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

11	NULL
,	NULL
69-75	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
Canova	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Schindler	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
158-167	NULL
Nichols	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nimer	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
2953-2963	NULL
Boutwood	NULL
,	NULL
J.	NULL
,	NULL
Fidler	NULL
,	NULL
C.	NULL
,	NULL
Lewis	NULL
,	NULL
S.	NULL
,	NULL
MacCarthy	NULL
,	NULL
A.	NULL
,	NULL
Sheridan	NULL
,	NULL
H.	NULL
,	NULL
Kelly	NULL
,	NULL
S.	NULL
,	NULL
Oscier	NULL
,	NULL
D.	NULL
,	NULL
Buckle	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
and	NULL
Wainscoat	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
2611-2616	NULL
Emilie	NULL
,	NULL
D.	NULL
,	NULL
Wijdenes	NULL
,	NULL
J.	NULL
,	NULL
Gisselbrecht	NULL
,	NULL
C.	NULL
,	NULL
Jarrousse	NULL
,	NULL
B.	NULL
,	NULL
Billaud	NULL
,	NULL
E.	NULL
,	NULL
Blay	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Gabarre	NULL
,	NULL
J.	NULL
,	NULL
Gaillard	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Brochier	NULL
,	NULL
J.	NULL
,	NULL
Raphael	NULL
,	NULL
M.	NULL
,	NULL
Boue	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Galanaud	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
8	NULL
,	NULL
2472-2479	NULL
Scambia	NULL
,	NULL
G.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Panici	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
Foti	NULL
,	NULL
E.	NULL
,	NULL
Martucci	NULL
,	NULL
R.	NULL
,	NULL
Gadducci	NULL
,	NULL
A.	NULL
,	NULL
Perillo	NULL
,	NULL
A.	NULL
,	NULL
Facchini	NULL
,	NULL
V.	NULL
,	NULL
Peschle	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mancuso	NULL
,	NULL
8	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
71	NULL
,	NULL
354-356	NULL
Liu	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Buchwald	NULL
,	NULL
M.	NULL
,	NULL
Walsh	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
N.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
3995-4007	NULL
Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Triggering	NULL
of	NULL
the	NULL
Human	NULL
Interleukin-6	NULL
Gene	NULL
by	NULL
Interferon-y	NULL
and	NULL
Tumor	NULL
Necrosis	NULL
Factor-	NULL
(	NULL
in	NULL
Monocytic	NULL
Cells	NULL
Involves	NULL
Cooperation	NULL
between	NULL
Interferon	NULL
Regulatory	NULL
Factor-1	NULL
,	NULL
NF	NULL
KB	NULL
,	NULL
and	NULL
Spl	NULL
Transcription	NULL
Factors	NULL
Josiane	NULL
Sancéau	NULL
,	NULL
Tsuneyasu	NULL
Kaisho	NULL
,	NULL
Toshio	NULL
Hirano	NULL
and	NULL
Juana	NULL
Wietzerbin	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:27920-27931.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.46.27920	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/46/27920	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
80	NULL
references	NULL
,	NULL
48	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

